0001193125-20-290935 | 10-Q | XBRL Viewer | Green Thumb Industries INC

Print Document View Excel Document

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2020	Nov. 05, 2020
Document Information [Line Items]
Document Type	10-Q
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Registrant Name	GREEN THUMB INDUSTRIES INC.
Entity Central Index Key	0001795139
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Address, State or Province	BC
Subordinate Voting Shares [Member]
Document Information [Line Items]
Title of 12(g) Security	Subordinate Voting Shares
Entity Common Stock, Shares Outstanding		175,040,286
Multiple Voting Shares [Member]
Document Information [Line Items]
Title of 12(g) Security	Multiple Voting Shares
Entity Common Stock, Shares Outstanding		6,779,300
Super Voting Shares [Member]
Document Information [Line Items]
Title of 12(g) Security	Super Voting Shares
Entity Common Stock, Shares Outstanding		31,203,100

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current Assets:
Cash and Cash Equivalents	$ 78,091,073	$ 46,667,334
Accounts Receivable	13,121,285	7,530,253
Inventories	55,164,258	46,034,481
Prepaid Expenses	6,990,373	6,780,657
Other Current Assets	5,692,248	2,049,886
Total Current Assets	159,059,237	109,062,611
Property and Equipment, Net	177,725,092	155,596,675
Right of Use Assets, Net	99,447,497	63,647,812
Investments	22,210,999	14,068,821
Investment in Associate	11,750,000	10,350,000
Notes Receivable		815,937
Intangible Assets, Net	409,655,517	435,246,898
Goodwill	373,081,716	375,084,991
Deposits and Other Assets	1,684,389	3,662,879
TOTAL ASSETS	1,254,614,447	1,167,536,624
Current Liabilities:
Accounts Payable	10,988,374	8,745,821
Accrued Liabilities	46,311,550	37,184,406
Current Portion of Notes Payable	301,027	206,675
Current Portion of Lease Liabilities	4,654,032	3,833,268
Liability for Acquisition of Noncontrolling Interest	0	5,500,000
Contingent Consideration Payable	27,100,000	50,391,181
Income Tax Payable	16,543,826	5,505,904
Total Current Liabilities	105,898,809	111,367,255
Long-Term Liabilities:
Lease Liabilities, Net of Current Portion	102,408,462	61,115,737
Notes Payable, Net of Current Portion and Debt Discount	96,758,233	91,140,194
Contingent Consideration Payable	9,215,360	8,545,558
Warrant Liability	18,513,000	15,879,843
Deferred Income Taxes	41,744,283	36,279,361
TOTAL LIABILITIES	374,538,147	324,327,948
COMMITMENTS AND CONTINGENCIES
SHARE HOLDERS' EQUITY
Share Capital	1,041,770,917	980,638,701
Contributed Surplus	1,656,498	3,960,854
Deferred Share Issuances	1,835,331	16,587,798
Accumulated Deficit	(167,963,430)	(160,491,590)
Equity of Green Thumb Industries Inc.	877,299,316	840,695,763
Noncontrolling interests	2,776,984	2,512,913
TOTAL SHAREHOLDERS' EQUITY	880,076,300	843,208,676
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	1,254,614,447	1,167,536,624
Subordinate Voting Shares [Member]
SHARE HOLDERS' EQUITY
Share Capital	0	0
Multiple Voting Shares [Member]
SHARE HOLDERS' EQUITY
Share Capital	0	0
Super Voting Shares [Member]
SHARE HOLDERS' EQUITY
Share Capital	$ 0	$ 0

Condensed Consolidated Balance Sheets (Parenthetical) - shares	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Subordinate Voting Shares [Member]
Common Stock, Shares Authorized	Unlimited	Unlimited
Common Stock, Shares, Issued	162,999,921	128,999,964
Common Stock, Shares, Outstanding	162,999,921	128,999,964
Multiple Voting Shares [Member]
Common Stock, Shares Authorized	Unlimited	Unlimited
Common Stock, Shares, Issued	120,910	373,350
Common Stock, Shares, Outstanding	120,910	373,350
Super Voting Shares [Member]
Common Stock, Shares Authorized	Unlimited	Unlimited
Common Stock, Shares, Issued	379,336	402,289
Common Stock, Shares, Outstanding	379,336	402,289

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Revenues, net of discounts	$ 157,103,841	$ 67,990,907	$ 379,346,367	$ 140,630,847
Cost of Goods Sold, net	(70,146,676)	(35,849,783)	(175,707,874)	(74,196,750)
Gross Profit	86,957,165	32,141,124	203,638,493	66,434,097
Expenses:
Selling, General, and Administrative	49,745,979	30,764,406	144,823,947	88,013,769
Total Expenses	49,745,979	30,764,406	144,823,947	88,013,769
Income (Loss) From Operations	37,211,186	1,376,718	58,814,546	(21,579,672)
Other Income (Expense):
Other Income (Expense), net	6,432,883	(6,585,540)	7,501,566	(7,969,433)
Interest Income, net	5,397	407,509	109,922	1,300,233
Interest Expense, net	(4,460,125)	(5,912,290)	(14,236,475)	(11,762,222)
Total Other Income (Expense)	1,978,155	(12,090,321)	(6,624,987)	(18,431,422)
Income (Loss) Before Provision for Income Taxes And Non-Controlling Interest	39,189,341	(10,713,603)	52,189,559	(40,011,094)
Provision For Income Taxes	28,436,332	3,624,333	56,964,047	4,706,000
Net Income (Loss) Before Non-Controlling Interest	10,753,009	(14,337,936)	(4,774,488)	(44,717,094)
Net Income Attributable to Non-Controlling Interest	1,109,080	252,857	2,697,352	328,804
Net Income (Loss) Attributable To Green Thumb Industries Inc.	$ 9,643,929	$ (14,590,793)	$ (7,471,840)	$ (45,045,898)
Net Income (Loss) per share - basic	$ 0.04	$ (0.07)	$ (0.04)	$ (0.24)
Net Income (Loss) per share - diluted	$ 0.04	$ (0.07)	$ (0.04)	$ (0.24)
Weighted average number of shares outstanding - basic	211,990,405	204,709,085	210,127,323	184,851,805
Weighted average number of shares - outstandingdiluted	214,212,292	204,709,085	210,127,323	184,851,805

Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)	Total	Share Capital [Member]	Shares To Be Issued [Member]	Contributed Surplus [Member]	Deferred Share Issuance [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]
Beginning balance at Dec. 31, 2018	$ 342,186,880	$ 397,590,465	$ 27,773,234	$ 14,202,659	$ 0	$ (100,876,937)	$ 3,497,459
Adoption of ASC 842, Leases	(498,246)	0	0	0	0	(498,246)	0
Noncontrolling interests adjustment for change in ownership	4,200,382	27,773,234	(27,773,234)	4,200,382	0	0	0
Contributions from limited liability company unit holders	1,650,000	0	0	0	0	0	1,650,000
Issuance of shares under business combinations and investments	485,755,272	509,568,665	0	(23,813,393)	0	0	0
Reciprocal derivative instrument	(4,526,401)	0	0	(4,526,401)	0	0	0
Issuance of shares for redemption of noncontrolling interests	25,068,847	29,889,374	0	(4,820,527)	0	0	0
Deferred share issuances	16,587,798	0	0	0	16,587,798	0	0
Stock based compensation	13,324,083	0	0	13,324,083	0	0	0
Shares withheld in lieu of cash	(125,060)	0	0	(125,060)	0	0	0
Distributions to third party and limited liability company unit holders	(7,516,061)	0	0	0	0	0	(7,516,061)
Net (loss) income	(44,717,094)	0	0	0	0	(45,045,898)	328,804
Ending balance at Sep. 30, 2019	831,390,400	964,821,738	0	(1,558,257)	16,587,798	(146,421,081)	(2,039,798)
Beginning balance at Jun. 30, 2019	830,103,975	950,736,500	0	(4,997,380)	16,587,798	(131,830,288)	(392,655)
Issuance of shares under business combinations and investments	14,085,326	14,085,238	0	88	0	0	0
Stock based compensation	3,564,095	0	0	3,564,095	0	0	0
Shares withheld in lieu of cash	(125,060)	0	0	(125,060)	0	0	0
Distributions to limited liability company unit holders	(1,900,000)	0	0	0	0	0	(1,900,000)
Net (loss) income	(14,337,936)	0	0	0	0	(14,590,793)	252,857
Ending balance at Sep. 30, 2019	831,390,400	964,821,738	0	(1,558,257)	16,587,798	(146,421,081)	(2,039,798)
Beginning balance at Dec. 31, 2019	843,208,676	980,638,701	0	3,960,854	16,587,798	(160,491,590)	2,512,913
Contributions from limited liability company unit holders	50,000	0	0	0	0	0	50,000
Issuance of shares under business combinations and investments	(153,929)	2,524,560	0	(2,678,489)	0	0	0
Issuance of shares for redemption of noncontrolling interests	5,350,000	20,078,940	0	(14,728,940)	0	0	0
Exercise of options and warrants	656,096	890,436	0	(234,340)	0	0	0
Stock based compensation	15,209,518	0	0	15,209,518	0	0	0
Distribution of contingent consideration	22,885,813	22,885,813	0	0	0	0	0
Distribution of deferred shares	0	14,752,467	0	0	(14,752,467)	0	0
Issueance of warrants	181,272	0	0	181,272	0	0	0
Distributions to third party and limited liability company unit holders	(2,536,658)	0	0	(53,377)	0	0	(2,483,281)
Net (loss) income	(4,774,488)	0	0	0	0	(7,471,840)	2,697,352
Ending balance at Sep. 30, 2020	880,076,300	1,041,770,917	0	1,656,498	1,835,331	(167,963,430)	2,776,984
Beginning balance at Jun. 30, 2020	851,398,319	1,004,812,062	0	6,545,712	15,280,000	(177,607,359)	2,367,904
Noncontrolling interests adjustment for change in ownership	5,700,000	0	0	5,700,000	0	0	0
Issuance of shares for redemption of noncontrolling interests	5,350,000	20,078,940	0	(14,728,940)	0	0	0
Exercise of options and warrants	448,424	744,332	0	(295,908)	0	0	0
Stock based compensation	4,435,634	0	0	4,435,634	0	0	0
Distribution of contingent consideration	2,690,914	2,690,914	0	0	0	0	0
Distribution of deferred shares	0	13,444,669	0	0	(13,444,669)	0	0
Distributions to third party and limited liability company unit holders	(700,000)	0	0	0	0	0	(700,000)
Net (loss) income	10,753,009	0	0	0	0	9,643,929	1,109,080
Ending balance at Sep. 30, 2020	$ 880,076,300	$ 1,041,770,917	$ 0	$ 1,656,498	$ 1,835,331	$ (167,963,430)	$ 2,776,984

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
CASH FLOW FROM OPERATING ACTIVITIES
Net loss attributable to Green Thumb Industries Inc.	$ (7,471,840)	$ (45,045,898)
Net income attributable to non-controlling interest	2,697,352	328,804
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	38,479,960	17,528,891
Amortization of operating lease assets	18,987,980	4,229,889
Loss on disposal of property and equipment	29,858
(Gain) loss from investment in associate		56,423
Bad debt expense	315,798
Deferred income taxes	4,377,000	(5,712,000)
Stock based compensation	15,209,520	13,324,083
Decrease (increase) in fair value of investments	(9,542,178)	886,002
Changes in value of liabilities related to put option and purchase of noncontrolling interests		(823,550)
Interest on contingent consideration payable and acquisition liabilities	998,842	3,258,804
Decrease in fair value of contingent consideration	(425,424)
Increase in fair value of warrant liability	2,060,771
Decrease in fair value of note receivable	815,937	7,424,727
Amortization of debt discount	4,048,531	2,100,738
Changes in operating assets and liabilities:
Accounts receivable	(5,616,054)	1,165,271
Inventories	(9,129,777)	(9,478,848)
Prepaid expenses and other current assets	(4,142,854)	(3,237,772)
Deposits and other assets	1,567,458	1,045,821
Accounts payable	2,242,553	1,707,947
Accrued liabilities	13,609,399	14,451,557
Operating lease liabilities	(12,674,176)	(4,184,228)
Income tax payable	14,617,544	260,535
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	71,056,200	(712,804)
CASH FLOW FROM INVESTING ACTIVITIES
Purchases of property and equipment	(49,221,442)	(66,875,245)
Proceeds from disposal of assets	11,799,025
Repayment of debenture investments		3,000,000
Purchase of businesses, net of cash acquired		(108,067,892)
NET CASH USED IN INVESTING ACTIVITIES	(37,422,417)	(171,943,137)
CASH FLOW FROM FINANCING ACTIVITIES
Contributions from limited liability company unit holders	50,000	1,650,000
Distributions to third parties and limited liability company unit holders	(2,536,658)	(7,516,061)
Proceeds from exercise of options and warrants	656,096
Proceeds from issuance of notes payable		117,435,724
Payment for purchase of noncontrolling interest	(150,000)
Principal repayment of notes payable	(229,482)	(18,778,140)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	(2,210,044)	92,791,523
CASH, CASH EQUIVALENTS AND RESTRICED CASH:
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	31,423,739	(79,864,418)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	46,667,334	145,986,072
CASH AND CASH EQUIVALENTS, END OF PERIOD	78,091,073	66,121,654
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid	9,418,727	5,964,621
NONCASH INVESTING AND FINANCING ACTIVITIES
Accrued capital expenditures	(6,798,187)	4,232,914
Noncash increase in right of use asset	(36,854,352)	(22,233,609)
Noncash increase in lease liability	$ 36,854,352	22,731,855
Net liability upon adoption of ASC 842, Leases		(498,246)
Exercise of put option		$ 4,200,382
Warrants attributable to debt issuance	753,658	0
Mortgages associated with dispensaries	$ 2,647,000
Liability for purchase of noncontrolling interest	(5,350,000)
Liability associated with acquisition agreement	2,000,000
Issuance of shares under acquisition agreement	(22,485,670)	$ (485,476,925)
Deferred share issuances	(14,752,467)	16,587,798
Inventory		13,602,245
Accounts receivable		2,117,412
Property and equipment	80,615	17,341,103
Right of use assets		4,154,672
Identifiable intangible assets	(145,000)	305,625,592
Goodwill	(2,003,275)	393,278,807
Deposits and other assets	603,988	1,694,533
Liabilities assumed	(1,302,604)	(9,489,616)
Lease liabilities		(4,154,672)
Equity interests issued	503,389	(485,476,925)
Contingent liabilities		(52,864,000)
Deferred share issuances		(16,587,798)
Conversion of note receivable previously issued		(27,025,800)
Acquisition liability	(228,813)	(1,630,893)
Deferred income taxes	2,491,700	(32,448,100)
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)		0
RECONCILIATION OF CASH, AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents	75,116,621	66,121,654
Restricted cash	2,974,452
TOTAL CASH, AND CASH EQUIVALENTS AND RESTRICED CASH	$ 78,091,073	$ 66,121,654

Overview and Basis of Presentation

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Overview and Basis of Presentation

1.	Overview and Basis of Presentation

(a)

Description of Business

Green Thumb Industries Inc. (“Green Thumb” or the “Company”) is promoting well-being through the power of cannabis through branded consumer packaged goods and people-first retail experiences, while being committed to community and sustainable profitable growth. Green Thumb owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including Beboe, Dogwalkers, Dr. Solomon’s, incredibles, Rythm and The Feel Collection, primarily to third-party retail stores across the United States as well as to Green Thumb owned retail stores. The Company also owns and operates retail cannabis stores that include a rapidly growing national chain of retail cannabis stores

ed Rise™ and a Las Vegas, Nevada area chain of retail cannabis stores

nam

ed Essence. As of September 30, 2020, Green Thumb has revenue in twelve markets (California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Nevada, New Jersey, New York, Ohio, and Pennsylvania).

On June 12, 2018, the Company completed a reverse takeover transaction (“RTO”) as further described in Note 3 of Green Thumb’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on April 15, 2020 (“2019 Form 10-K”). Following the RTO, the Company was listed on the Canadian Securities Exchange (the “CSE”) under ticker symbol “GTII” and on the OTCQX, part of the OTC Markets Group, under the ticker “GTBIF”.

The Company’s registered office is located at 885 West Georgia Street, Suite 2200, Vancouver, British Columbia, V6C 3E8, Canada. The Company’s U.S. headquarters are at 325 W. Huron St., Suite

700

, Chicago, IL 60654.

(b)

Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements include the accounts of Green Thumb Industries Inc. and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and, accordingly, certain information, footnotes and disclosures normally included in the annual financial statements, prepared in accordance with GAAP, have been condensed or omitted in accordance with SEC rules and regulations. The financial data presented herein should be read in conjunction with the audited consolidated and combined financial statements and accompanying notes included in the 2019 Form 10-K. In the opinion of management, the financial data presented includes all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Results of interim periods should not be considered indicative of the results for the full year. These unaudited interim condensed consolidated financial statements include estimates and assumptions of management that affect the amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from these estimates.

Certain previously reported amounts have been reclassified between line items to conform to the current presentation. The reclassifications did not affect the Company’s previously reported consolidated balance sheets, consolidated statements of operations, statements of cash flows or statements of changes in shareholders’ equity.

The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the entire year ending December 31, 2020.

(c)

Significant Accounting Policies

There have been no changes to the Company’s significant accounting policies as described in Note 2 of the Company’s 2019 Form 10-K.

(d)

Earnings (Loss) per Share

Basic earnings (loss) per share is calculated by dividing the net income (loss) attributable to shareholders by the weighted average number of common shares (Subordinate Voting Shares, Multiple Voting Shares on an as converted basis, and Super Voting Shares on an as converted basis) outstanding during each of the periods presented. Contingently issuable shares (including shares held in escrow) are not considered outstanding common shares and consequently are not included in the basic earnings (loss) per share calculations. Diluted earnings (loss) per share is calculated using the treasury stock method by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company has three categories of potentially dilutive common share equivalents: restricted stock units, stock options and warrants. At September 30, 2020, the Company had 5,782,599 options, 688,507 restricted stock units and 2,520,794 warrants outstanding. At September 30, 2019, the Company had 6,031,833 options, 1,479,038 restricted stock units and 2,041,735 warrants outstanding.

In order to determine diluted earnings (loss) per share, it is assumed that any proceeds from the exercise of dilutive unvested restricted stock units, stock options, and warrants would be used to repurchase common shares at the average market price during the period. Under the treasury stock method, the diluted loss per share calculation excludes any potential exercise of restricted stock units, stock options or warrants that would decrease loss per share. For the three months ended September 30, 2020, the computation of diluted loss per share included 1,928,946 options, 151,458 restricted stock units and 141,482 warrants. No potentially dilutive common share equivalents were included in the computation of diluted loss per share for the three months ended September 30, 2019 and nine months ended September 30, 2020 and 2019 because their impact was anti-dilutive.

(e)

Recently Adopted Accounting Standards

(i)

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which replaces the incurred loss model with a current expected credit loss (“CECL”) model and requires consideration of a broader range of reasonable and supportable information to explain credit loss estimates. This standard applies to financial assets, measured at amortized cost, including loans, held-to-maturity debt securities, net investments in leases and trade accounts receivable. The guidance must be adopted using a modified retrospective transition method through a cumulative-effect adjustment to retained earnings in the period of adoption. The Company adopted the new standard in the first quarter of 2020. The adoption of the standard did not have a material impact on the Company’s unaudited interim condensed consolidated financial statements.

(ii)

In January 2017, the FASB issued Accounting Standards Update No. 2017-04 “Intangibles— Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment” (“ASU 2017-04”), which simplifies the accounting for goodwill impairment. ASU 2017-04 requires entities to record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value (Step 1 under the current impairment test). The standard eliminates Step 2 from the current goodwill impairment test, which included determining the implied fair value of goodwill and comparing it with the carrying amount of that goodwill. ASU 2017-04 must be applied prospectively and is effective in the first quarter of 2020. Early adoption is permitted. The Company adopted the new standard in the first quarter of 2020. The adoption of the standard did not have a material impact on the Company’s unaudited interim condensed consolidated financial statements.

(iii)

In August 2018, the FASB issued ASU 2018-13, Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820)(“ASU 2018-13”). ASU 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019. The Company adopted the new standard in the first quarter of 2020. The adoption of the standard did not have a material impact on the Company’s unaudited interim condensed consolidated financial statements.

(f)

Recently Issued Accounting Standards

(i)

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes (“ASU 2019-12”). ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for the Company beginning January 1, 2021. The Company is currently evaluating the effect of adopting this ASU on the Company’s financial statements.

(ii)

In January 2020, the FASB issued ASU 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU 2020-01”), which is intended to clarify the interaction of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. ASU 2020-01 is effective for the Company beginning January 1, 2021. The Company is currently evaluating the effect of adopting this ASU on the Company’s financial statements.

(iii)

On August 5, 2020, the FASB issued Accounting Standards Update No. 2020-06,

Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity,

to improve financial reporting associated with accounting for convertible instruments and contracts in an entity’s own equity. The amendments in this Update are effective for public business entities that meet the definition of a Securities and Exchange Commission (“SEC”) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The FASB specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company is currently evaluating the effect of adopting this ASU on the Company’s financial statements.

(g)

Coronavirus Pandemic

In March 2020, the World Health Organization categorized coronavirus disease 2019 (“COVID-19”) as a pandemic. COVID-19 continues to spread throughout the U.S. and other countries across the world, and the duration and severity of its effects are currently unknown. The Company is implementing and evaluating actions to strengthen its financial position and support the continuity of its business and operations.

The Company’s unaudited interim condensed consolidated financial statements presented herein reflect estimates and assumptions made by management that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited interim condensed consolidated financial statements and reported amounts of revenue and expenses during the periods presented. Such estimates and assumptions affect, among other things, the Company’s goodwill, long-lived assets and intangible assets; operating lease right of use assets and operating lease liabilities; assessment of the annual effective tax rate; valuation of deferred income taxes; the allowance for doubtful accounts; assessment of the Company’s lease and non-lease contract expenses; and measurement of compensation cost for bonus and other compensation plans. While the Company’s revenue, gross profit and operating income were not impacted during the first nine months of 2020, the uncertain nature of the spread of COVID-19 may impact the Company’s business operations for reasons including the potential quarantine of the Company’s employees or those of its supply chain partners, and the Company’s

continued

designation as

“essential”

business

in states where the Company does business that currently or in the future impose restrictions on

its

business operations. The estimates and assumptions used in the unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2020 include, but are not limited to certain judgmental reserves requiring management to makes estimates based on current information. The carrying value of the Company’s goodwill and other long-lived assets, may change in future periods as the expected impacts from COVID-19 are revised, resulting in further potential impacts to the Company’s financial statements.

Inventories

9 Months Ended

Sep. 30, 2020

Inventory Disclosure [Abstract]

Inventories

2.	INVENTORIES

The Company’s inventories include the following at September 30, 2020 and December 31, 2019:


	September 30,			December 31,
	2020			2019
Raw Material	$	3,603,977		$	6,375,032
Packaging and Miscellaneous		6,173,017			4,887,970
Work in Process		24,945,006			20,162,723
Finished Goods		22,430,016			16,640,629
Reserve for Obsolete Inventory		(1,987,758	)		(2,031,873	)


Total Inventories	$	55,164,258		$	46,034,481

Property and Equipment

9 Months Ended

Sep. 30, 2020

Property, Plant and Equipment [Abstract]

Property and Equipment

3.	PROPERTY AND EQUIPMENT

At September 30, 2020, property and equipment consisted of the following:


Cost	Land			Buildings and Improvements			Equipment, Computers and Furniture		Leasehold Improvements		Capitalized Interest		Assets Under Construction			Total
As at January 1, 2020	$	3,272,439		$	33,377,471		$	35,509,871	$	68,681,497	$	2,500,000	$	21,372,116		$	164,713,394
Additions		586.867			21,128,482			4,794,342		12,413,970		342,966		6,118,878			45,385,505
Disposals		(979,930	)		(4,507,086	)		—		—		—		(6,978,389	)		(12,465,405	)

As at September 30, 2020	$	2,879,376		$	49,998,867		$	40,304,213	$	81,095,467	$	2,842,966	$	20,512,605		$	197,633,494


Accumulated Depreciation
As at January 1, 2020	$	—		$	2,236,254		$	3,882,178	$	2,998,287	$	—	$	—		$	9,116,719
As at September 30, 2020	$	—		$	2,939,951		$	8,375,318	$	8,426,333	$	166,800	$	—		$	19,908,402

Net book value
As at January 1, 2020	$	3,272,439		$	31,141,217		$	31,627,693	$	65,683,210	$	2,500,000	$	21,372,116		$	155,596,675
As at September 30, 2020	$	2,879,376		$	47,058,916		$	31,928,895	$	72,669,134	$	2,676,166	$	20,512,605		$	177,725,092

At December 31, 2019, property and equipment consisted of the following:


Cost	Land			Buildings and Improvements			Equipment, Computers and Furniture			Leasehold Improvements		Capitalized Interest		Assets Under Construction		Total
As at January 1, 2019	$	2,243,085		$	20,861,988		$	11,001,498		$	18,435,893	$	—	$	16,664,958	$	69,207,422
Additions		4,393,030			28,217,500			23,109,209			38,002,678		2,500,000		4,678,084		100,900,501
Additions from acquisitions		—			—			4,253,362			12,242,926		—		29,074		16,525,362
Disposals		(3,363,676	)		(15,702,017	)	$	(2,854,198	)		—		—		—		(21,919,891	)

As at December 31, 2019	$	3,272,439		$	33,377,471		$	35,509,871		$	68,681,497	$	2,500,000	$	21,372,116	$	164,713,394


Accumulated Depreciation
As at January 1, 2019	$	—		$	1,351,230		$	1,524,114		$	1,007,998	$	—	$	—	$	3,883,342
As at December 31, 2019	$	—		$	2,236,254		$	3,882,178		$	2,998,287	$	—	$	—	$	9,116,719

Net book value
As at January 1, 2019	$	2,243,085		$	19,510,758		$	9,477,384		$	17,427,895	$	—	$	16,664,958	$	65,324,080
As at December 31, 2019	$	3,272,439		$	31,141,217		$	31,627,693		$	65,683,210	$	2,500,000	$	21,372,116	$	155,596,675

Assets under construction represent construction in progress related to both cultivation and dispensary facilities not yet completed or otherwise not ready for use.

Depreciation expense for the three and nine months ended September 30, 2020 totaled $2,003,585 and $11,193,570, respectively of which $311,315 and $5,571,477, respectively, is included in cost of goods sold. Depreciation expense for the three and nine months ended September 30, 2019 totaled $2,494,601 and $5,113,195, respectively of which $1,732,146 and $3,541,236, respectively, is included in cost of goods sold.

On January 31, 2020, the Company closed a sale and lease back transaction to sell its Toledo, Ohio processing facility to Innovative Industrial Properties (“IIP”). Under the long-term agreement, the Company will lease back the facility and continue to operate and manage it. As a result of the sale, the Company disposed

of $205,000 of land and $2,695,000 of construction in progress. There was no gain or loss on the sale.

On March 6, 2020, the Company closed a sale and lease back transaction to sell its Oglesby, Illinois cultivation and processing facility to IIP. Under the long-term agreement, the Company will lease back the facility and continue to operate and manage it. As a result of the sale, the Company disposed

of $774,930 of land, $4,507,086 of buildings and improvements and $3,813,636 of construction in progress. The Company recognized a gain on the sale of Oglesby facility of $239,096 which was recorded within other income (expense) on the unaudited interim condensed consolidated statement of operations.

For further information regarding these transactions, see Note 5 - Leases.

Intangible Assets And Goodwill

9 Months Ended

Sep. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill

4.	INTANGIBLE ASSETS AND GOODWILL

Intangible assets are recorded at cost less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is provided on a straight-line basis over their estimated useful lives. The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively.

At September 30, 2020 intangible assets consisted of the following:


	Licenses and Permits			Tradenames		Customer Relationships		Non-Competition Agreements		Total
Cost
As at January 1, 2020	$	336,954,213		$	97,455,590	$	25,258,000	$	2,585,480	$	462,253,283
Adjustments to Purchase Price Allocation		(145,000	)		1,840,009		—		—		1,695,009

As at September 30, 2020	$	336,809,213		$	99,295,599	$	25,258,000	$	2,585,480	$	463,948,292

Accumulated Amortization
As at January 1, 2020	$	18,477,500		$	4,121,800	$	3,932,416	$	474,669	$	27,006,385
Amortization		17,701,556			6,412,282		2,777,802		394,750		27,286,390

As at September 30, 2020	$	36,179,056		$	10,534,082	$	6,710,218	$	869,419	$	54,292,775

Net book value
As at January 1, 2020	$	318,476,713		$	93,333,790	$	21,325,584	$	2,110,811	$	435,246,898
As at September 30, 2020	$	300,630,157		$	88,761,517	$	18,547,782	$	1,716,061	$	409,655,517

At December 31, 2019 intangible assets consisted of the following:


	Licenses and Permits		Tradenames		Customer Relationships		Non-Competition Agreements		Total
Cost
As at January 1, 2019	$	89,705,213	$	360,000	$	820,000	$	20,480	$	90,905,693
Additions from acquisitions		247,249,000		97,095,590		24,438,000		2,565,000		371,347,590

As at December 31, 2019	$	336,954,213	$	97,455,590	$	25,258,000	$	2,585,480	$	462,253,283

Accumulated Amortization
As at January 1, 2019	$	2,322,715	$	—	$	204,500	$	12,800	$	2,540,015
Amortization		16,154,785		4,121,800		3,727,916		461,869		24,466,370

As at December 31, 2019	$	18,477,500	$	4,121,800	$	3,932,416	$	474,669	$	27,006,385

Net book value
As at January 1, 2019	$	87,382,498	$	360,000	$	615,500	$	7,680	$	88,365,678
As at December 31, 2019	$	318,476,713	$	93,333,790	$	21,325,584	$	2,110,811	$	435,246,898

The Company recorded amortization expense for the three and nine months ended September 30, 2020 of $9,531,290 and $27,286,390, respectively, and for the three and nine months ended September 30, 2019 of $5,419,212, and $12,415,696, respectively. During the second quarter of 2020, the Company recorded a measurement period adjustment in connection with its June 27, 2019 acquisition of MC Brands, LLC of $1,840,009 which increased intangible assets and share capital. The remainder of the adjustments to purchase price allocations relate to the finalization of several 2019 acquisitions.

In addition, the Company reviewed the estimated useful lives of its intangible assets as part of the Company’s plans to rebrand one of its retail stores. Based on that review, the Company determined that certain intangible assets associated with the Company’s retail tradenames have a useful life shorter than initially estimated.

Beginning July 1, 2020, the Company adjusted the useful life of its retail tradename associated with the acquisition of Essence from 15 years to 7 years. The change in useful life was made as a prospective adjustment and resulted in an increase in amortization expense of $1,266,880 for the remainder of 2020, $5,067,520 annually for years 2021 through 2024, and a net reduction in amortization expense of $21,536,960 thereafter.

The following table outlines the estimated annual amortization expense related to intangible assets as of September 30, 2020 and illustrates the effect of the change in useful life of the Essence tradename discussed above:


Year Ending December 31,	Estimated Amortization (Prior to Change in Useful Life)		Increase (Decrease) from Change in Useful Life			Estimated Amortization (After Change in Useful Life)
Remainder of 2020	$	8,426,261	$	1,266,880		$	9,693,141
2021		33,705,044		5,067,520			38,772,564
2022		33,274,305		5,067,520			38,341,825
2023		33,191,489		5,067,520			38,259,009
2024		32,610,156		5,067,520			37,677,676
Thereafter		268,448,262		(21,536,960	)		246,911,302

	$	409,655,517	$	—		$	409,655,517

Goodwill

At September 30, 2020, Goodwill consisted of the following:


	Retail		Consumer Packaged Goods			Total
As at January 1, 2020	$	119,873,759	$	255,211,232		$	375,084,991
Adjustments to Purchase Price Allocations		1,191,425		(3,194,700	)		(2,003,275	)

As at September 30, 2020	$	121,065,184	$	252,016,532		$	373,081,716

At December 31, 2019, Goodwill consisted of the following:


	Retail		Consumer Packaged Goods			Total
As at January 1, 2019	$	15,286,360	$	23,918,000		$	39,204,360
Acquisition of Advanced Grow Labs, LLC		16,756,250		44,572,349			61,328,599
Acquisition of Integral Associates, LLC		46,655,753		69,323,570			115,979,323
Other Acquisitions		32,936,590		120,963,598			153,900,188
Adjustments to Purchase Price Allocations		8,238,808		(3,566,285	)		4,672,523

As at December 31, 2019	$	119,873,759	$	255,211,232		$	375,084,991

During the nine months ended September 30, 2020, the Company recorded measurement period adjustments resulting in a net decrease in goodwill of $2,003,275 associated

with

various acquisitions. In regard to the Consumer Packaged Goods segment, the Company recorded measurement period adjustments associated with its acquisition of For Success Holdings Company and Advanced Grow Labs, LLC of $1,687,700 and $1,507,000, respectively, which represented a reduction in the value of goodwill and deferred tax liabilities. Regarding the Retail segment, the Company recorded measurement period adjustments associated with its acquisition of Fiorello Pharmaceuticals, Inc. of $1,000,000 which represented an increase in the value of goodwill and corresponding adjustment to current liabilities. The remainder of the adjustments to the Retail segment represent the finalization of purchase price allocations related to other 2019 acquisitions.

Leases

9 Months Ended

Sep. 30, 2020

Leases [Abstract]

Leases of Lessee Disclosure [Text Block]

LEASES

(a)

Operating Leases Under Accounting Standards Update

No. 2016-02

In February 2016, the FASB issued ASU No. 2016-02 - Leases (Topic 842) (“ASU 2016-02”), which requires lessees to put most leases on the balance sheet but recognize expense on the income statement in a manner similar to current accounting. On January 1, 2019, the Company adopted the ASU 2016-02 and all related amendments, using the optional transition method (modified retrospective approach) applied to leases at the adoption date. Under the modified retrospective approach, comparative periods have not been restated and continue to be reported under the accounting standards in effect for those periods. Additionally, an adjustment was recorded to accumulated deficit to account for the initial adoption of the standard.

For additional information regarding the adoption of ASU

2016-02,

see Note 9 – Leases in the 2019 Form

10-K

Other information related to operating leases as of and for the three and nine months ending September 30, 2020 were as follows:


	As of September 30, 2020
Weighted average remaining lease term		10.81
Weighted average discount rate		13.2	%

Maturities of lease liabilities for operating leases as of September 30, 2020 were as follows:


	Maturities of Lease Liability
	Third Party			Related Party			Total
Remainder of 2020	$	4,767,957		$	322,287		$	5,090,244
2021		22,243,662			1,307,183			23,550,845
2022		22,285,836			1,337,130			23,622,966
2023		22,092,882			1,367,771			23,460,653
2024		21,387,294			1,255,714			22,643,008
2025 and Thereafter		183,998,689			10,345,330			194,344,019

Total Lease Payments		276,776,320			15,935,415			292,711,735

Less: Interest		(177,811,636	)		(7,837,605	)		(185,649,241	)

Present Value of Lease Liability	$	98,964,684		$	8,907,810		$	107,062,494

For the three and nine months ended September 30, 2020 the Company recorded operating lease expense of $6,590,553 and $19,021,190, respectively. For the three and nine months ended September 30, 2019, the Company recorded operating lease expenses of $1,962,561 and $4,229,889, respectively.

(b)

Related Party Operating Leases

The Company entered into related party transactions with respect to its leasing arrangements for

certain

facilities in Florida, Illinois, Maryland, Massachusetts and Nevada.

Wendy Berger, a director of the Company, is a principal of WBS Equities, LLC, which is the Manager of Mosaic Real Estate, LLC, and owns certain facilities leased by the Company. Additionally, Mosaic Real Estate, LLC is owned in part by Ms. Berger (through the Wendy

Berger 1998 Revocable Trust), Benjamin Kovler, the Chief Executive Officer and a director of the Company (through KP Capital, LLC), and Anthony Georgiadis, the Chief Financial Officer and a director of the Company (through Three One Four Holdings, LLC). The terms of these leases range from 7 years to 15 years. For the three and nine months ended September 30, 2020, the Company recorded lease expense of $157,076 and $601,753, respectively, associated with these leasing arrangements. For the three and nine month ended September 30, 2019, the Company recorded operating lease expenses of $148,226 and $339,961, respectively, associated with these leasing arrangements.

On June 5, 2020, a wholly owned subsidiary of the Company purchased the building and building improvements of the Company’s dispensary located in Joliet, Illinois for $1,814,000 from Mosaic Real Estate Joliet, LLC. The transaction resulted in the termination of the Illinois related party leasing arrangement. For additional information see Note 6 – Notes Payable.

In connection with the Company’s acquisition of Integral Associates, LLC, the Company, through a subsidiary, leases property from Durango Teco Partners, LLC, which commenced on June 27, 2020 for an Essence retail store in Nevada. Durango Teco Partners, LLC is owned in part by Armenco Capital LLC, which is in turn owned in part by Alejandro Yemenidjian, a former owner of Integral Associates, LLC and a current director of the Company. The lease has a ten year term. For the three and nine months ended September 30, 2020, the Company recorded lease expense of $58,332 and $77,776, respectively, associated with this lease.

(c)

Sales Lease Back Transactions

On January 31, 2020, the Company closed on a sale and lease back transaction to sell its Toledo, Ohio processing facility to IIP. Under a long-term agreement, the Company has leased back the facility and continues to operate and manage it. The purchase price for the property was $2,900,000, excluding transaction costs. The Company is making certain improvements to the property that will significantly enhance production capacity, for which IIP has agreed to provide reimbursement of up to $4,300,000.

Following the end of the third quarter of 2020, on

October 1, 2020, the Company and IIP agreed to amend the lease on the Toledo, Ohio processing facility. Under the amendment, IIP will provide an additional $25,000,000 in funding to be used for the construction of a cannabis cultivation facility at the property, which currently houses a separate cannabis processing facility. Assuming full payment of the additional funding, IIP’s total investment in the property pursuant to the sale and leaseback transaction and related amendment will be $32,200,000. The Company is in process of evaluating the lease amendment and will conclude on the classification, and value of the right of use asset and related lease liability in the following quarter.

On March 6, 2020, the Company closed on a sale and lease back transaction to sell its Oglesby, Illinois cultivation and processing facility to IIP. Under a long-term agreement, the Company has leased back the facility and continues to operate and manage it. The purchase price for the property was $9,000,000, excluding transaction costs. The Company is making certain improvements to the property that will significantly enhance production capacity, for which IIP has agreed to provide reimbursement of up to $41,000,000. Assuming full reimbursement for such improvements, IIP’s total investment in the property will be $50,000,000. The lease has a term of 16 years and was recorded as an operating lease and resulted in a right of use asset and related lease liability of $26,828,221 and was recorded net of the improvements allowance of $41,000,000.

Notes Payable

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Notes Payable

6.	NOTES PAYABLE

At September 30, 2020 and December 31, 2019, notes payable consisted of the following:


	September 30, 2020			December 31, 2019

In connection with an acquisition completed in 2017, the Company is required to make quarterly charitable contributions of $50,000 through October 2024. The net present value of these required payments has been recorded as a liability with an interest rate of 2.17%.	$	763,284		$	970,957

Private placement debt dated May 22, 2019, in the original amount of $105,466,429 with an interest rate of 12.00%, matures on May 22, 2023. The debt was issued at a discount, the carrying value of which is $11,618,400 as of September 30, 2020		93,848,029			90,375,912

Rise Joliet mortgage dated June 5, 2020, in the original amount of $1,814,000 with an interest rate of 5.00%, matures on June 5, 2035. The debt was issued at a discount, the carrying value of which is $177,244 as of September 30, 2020.		1,616,606			—

Rise Lakewood mortgage dated August 20, 2020, in the original amount of $833,000 with an interest rate of 7.25%, matures on August 20, 2025.		831,341			—

Total notes payable		97,059,260			91,346,869
Less: current portion of notes payable		(301,027	)		(206,675	)

Notes payable, net of current portion	$	96,758,233		$	91,140,194

(a)

Extension of Private Placement Financing

On May 21, 2020, the Company exercised its option to extend the maturity date of its senior secured notes (the “Notes”) pursuant to the Note Purchase Agreement, dated May 22, 2019, as amended (the “Note Purchase Agreement”) for an additional year. Following this exercise, which was in the Company’s sole discretion under the Note Purchase Agreement, the new maturity date for the Notes is May 22, 2023.

(b)

Mortgage on Joliet, Illinois Dispensary

On June 5, 2020, the Company closed on a secured promissory note (the “Mortgage”) of $1,814,000. The Mortgage bears interest of 5% per annum and matures on June 5, 2035. The Mortgage provided by the lender was used to purchase the building and building improvements of one of the Company’s dispensaries located in Joliet, Illinois that the Company previously leased from Mosaic Real Estate Joliet, LLC, a related party. As part of the transaction, the Company issued 35,000 warrants valued at $181,272

using a Black Scholes Option Pricing model which were accounted for as equity and recorded as a discount on the Mortgage.

(c)

Mortgage on Lakewood, Ohio Dispensary

On August 20, 2020, the Company closed on a secured promissory note (the “Lakewood Mortgage”)

of $833,000.

The Lakewood Mortgage bears interest

of 7.25% per annum and matures on August 20, 2025.

The Lakewood Mortgage provided by the lender was used to purchase the land, building and building improvements of one of the Company’s dispensaries located in Lakewood, Ohio that the company previously leased.

(d)

Related Parties

The private placement debt is held by related parties as well as unrelated third-party lenders at a percentage of approximately 1% and 99%,

respectively. The related parties consist of Benjamin Kovler, the Chief Executive Officer and a director of the Company (through KP Capital, LLC); Andrew Grossman, the Executive Vice President of Capital Markets of the Company (through AG Funding Group, LLC); and Anthony Georgiadis, the Chief Financial Officer and a director of the Corporation (through Three One Four Holdings, LLC and ABG, LLC).

Warrants

9 Months Ended

Sep. 30, 2020

Warrants and Rights Note Disclosure [Abstract]

Warrants

WARRANTS

As part of the Company’s private placement financing and Mortgage on the Joliet, Illinois dispensary, the Company issued warrants to related parties, as well as

un-related

third parties, which allow the holders to purchase Subordinate Voting Shares at an exercise price determined at the time of issuance.

The following table summarizes the number warrants outstanding as of September 30, 2020 and December 31, 2019:


	Number of Shares				Weighted Average Exercise Price (C$)		Weighted Average Contractual Life		Number of Shares		Weighted Average Exercise Price (USD)		Weighted Average Contractual Life
	Liability Classified								Equity Classified
Balance as at December 31, 2019		2,406,811		C$		18.59		4.86		-	$	-		-
Additional Modification Warrants		84,924				14.03		5.00		-		-		-
Dispensary Mortgage Warrants		-				-		-		35,000		9.10		5.00
Warrants Exercised		(5,941	)			12.42		5.00		-		-		-

Balance as at September 30, 2020		2,485,794		C$		18.45		4.87		35,000	$	9.10		5.00

(a)

Additional Modification Warrants

As part of the November 9, 2019 modification of the Notes, the Company agreed to issue 84,924 additional warrants by May 22, 2020 to participating lenders in the event the Company decided to raise additional capital or to the original lenders involved in the May 22, 2019 private placement financing in the event the Company did not. On May 21, 2020, the Company issued the warrants to the original lenders involved in the private placement financing which allows the holder to purchase 84,924 Subordinate Voting Shares. The warrants are denominated in CAD. Upon issuance, the Company recorded an additional amount to debt discount with a corresponding amount to the warrant liability of $572,387,

which was measured at fair value using the following assumptions:


Significant Assumptions	May 21, 2020 (Date of Issuance)
Volatility		100	%
Remaining Term		5 years
Risk Free Rate		0.42	%

(b)

Dispensary Mortgage Warrants

On June 5, 2020, as part of the $1,814,000 promissory note, the Company issued warrants that allow the promissory noteholder to purchase 35,000 Subordinate Voting Shares. These warrants are denominated in USD, which is the Company’s functional currency. As such, upon issuance, the Company recorded an additional amount to debt discount with a corresponding amount to contributed surplus of $181,272 which was measured at fair value using a Black Scholes Options Pricing model. The Company did not incur any other material fees related to the promissory note.

(c)

Liability Classified Warrants Outstanding

The following table summarizes the fair value of the liability classified warrants at September 30, 2020 and December 31, 2019:


Warrant Liability	Strike Price		Warrants Outstanding		September 30, 2020		December 31, 2019
Bridge Financing Warrants	C$	22.90		218,964	$	1,065,000	$	1,385,400
Private Placement Financing Warrants	C$	19.39		1,822,771		13,457,000		12,189,169
Modification Warrants	C$	12.04		360,256		3,251,500		2,305,274
Additional Modification Warrants	C$	14.03		83,803		739,500		—

Totals				2,485,794	$	18,513,000	$	15,879,843

During the three and nine months ended September 30, 2020, the Company recorded a loss of $3,181,114 and a loss of $2,060,770, respectively, on the change in the fair value of the warrant liability within other income (expense) on the unaudited interim condensed consolidated statements of operations.

The following table summarizes the significant assumptions used in determining the fair value of the warrant liability as of each reporting date

ee Note 13 - Fair Value Measurements for additional details

)


Significant Assumptions	September 30, 2020		December 31, 2019
Volatility		85.36 % - 89.50 %		117.43 % - 123.64 %
Remaining Term		2.03 - 4.64 years		2.78 - 4.86 years
Risk Free Rate		0.25 % - 0.34 %		1.68% - 1.69 %

(e)

Equity Classified Warrants Outstanding

The following table summarizes the fair value of the equity classified warrants at September 30, 2020 and December 31, 2019:


Warrants Included in Contributed Surplus	Strike Price		Warrants Outstanding		September 30, 2020		December 31, 2019
Dispensary Mortgage Warrants	$	9.10		35,000	$	181,272	$	—

The following table summarizes the significant assumptions used in determining the fair value of the equity classified warrants as of each reporting date:


Significant Assumptions	September 30, 2020			December 31, 2019
Volatility		80	%		—
Remaining Term		5 years			—
Risk Free Rate		0.37	%		—

Income Taxes

9 Months Ended

Sep. 30, 2020

Income Tax Disclosure [Abstract]

Income Taxes

8.	INCOME TAXES

The following table summarizes the Company’s income tax expense and effective tax rates for the three and nine months ended September 30, 2020 and September 30, 2019:


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020			2019			2020			2019
Income/(Loss) before Income Taxes	$	39,189,341		$	(10,713,603	)	$	52,189,559			(40,011,094	)
Income Tax Expense	$	28,436,332		$	3,624,333		$	56,964,047			4,706,000
Effective Tax Rate		72.6	%		-33.8	%		109.1	%		-11.8	%

Historically, the Company has calculated its provision for income taxes during its interim reporting periods by applying an estimate of the annual effective tax rate for the full year “ordinary” income or loss for the respective reporting period. For the nine months ended September 30, 2020, the Company has computed its provision for income taxes under the discrete method which treats the year-to-date period as if it were the annual period and determines the income tax expense or benefit on that basis. The discrete method is applied when application of the estimated annual effective tax rate is impractical because it is not possible to reliably estimate the annual effective tax rate. We believe that, at this time, the use of this discrete method is more appropriate than the annual effective tax rate method as the estimated annual effective tax rate method is not reliable due to the high degree of uncertainty in estimating annual pre-tax income due to the early growth stage of the business.

Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed

non-allowable

under IRC Section 280E.

The effective tax rate for the three and nine months ended September 30, 2020 varies widely from the three and nine months ended September 30, 2019, respectively, primarily due to the Company reporting pre-tax loss in 2019 as opposed to pre-tax income in 2020.

The Company incurred a large amount of expenses that were not deductible due to IRC Section 280E limitations which resulted in income tax expense being incurred while there were pre-tax losses for the three and nine months ended September 2019.

The Company is subject to income taxes in the United States and Canada. Significant judgment is required in evaluating the Company’s uncertain tax positions and determining the provision for income taxes. The Company’s gross unrecognized tax benefits were approximately $16,264,727 and $2,113,263 as of September 30, 2020 and December 31, 2019, respectively, recorded within Deferred Income Taxes.

The federal statute of limitation remains open for the 2017 tax year to the present. The state income tax returns generally remain open for the 2016 tax year through the present. Net operating losses arising prior to these years are also open to examination if and when utilized.

Taxes paid during the nine months ended September 30, 2020 and 2019 were $37,820,228 and $10,534,408, respectively.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

Investments

9 Months Ended

Sep. 30, 2020

Investments [Abstract]

Investments

9.	INVESTMENTS

The Company holds direct equity investments in cannabis companies, some of which converted from notes which matured August 1, 2020. The following table summarizes the change in the Company’s investments as of September 30, 2020:


	Convertible Notes Receivable			Equity		Total
Balance at January 1, 2020	$	7,533,000		$	6,535,821	$	14,068,821
Additions		—			25,000		25,000
Conversion of notes receivable		(7,533,000	)		7,533,000		—
Fair value adjustment		—			8,117,178		8,117,178

Balance at September 30, 2020	$	—		$	22,210,999	$	22,210,999

As of September 30, 2020, the Company updated its valuation for the notes that converted to equity as well as certain equity investments. The equity investments were valued using a market approach using the following significant assumptions:


		September 30, 2020
Discount for lack of control		13%
Discount for lack of marketability		10%-30%

The following table summarizes the change in the Company’s investments as of December 31, 2019:


	Convertible Notes Receivable			Equity			Total
Balance at January 1, 2019	$	30,336,000		$	10,597,283		$	40,933,283
Fair value adjustment		(1,398,000	)		(4,061,462	)		(5,459,462	)
Applied to consideration in business combination		(21,405,000	)		—			(21,405,000	)

Balance at December 31, 2019	$	7,533,000		$	6,535,821		$	14,068,821

The calculated fair values are recorded as a Level 3 fair value investment as of September 30, 2020 and December 31, 2019. See Note 13 - Fair Value Measurements for additional details. As of December 31, 2019, the convertible notes receivable were valued using the Binomial Lattice Model, which is based on a generalized binomial option pricing formula, using the following assumptions:


		December 31, 2019
Risk free rate		1.58% -2.46%
Equity Volatility		58% - 106%
Market Yield		15% - 18%
Probability of Qualified Financing		0%
Probability of Sale		30%
Probability of No Event		70%

Share Capital

9 Months Ended

Sep. 30, 2020

Stockholders' Equity Note [Abstract]

Share Capital

10.	SHARE CAPITAL

Common shares, which include the Company’s Subordinate Voting Shares, Multiple Voting Shares and Super Voting Shares, are classified as equity. Incremental costs directly attributable to the issuance of shares are recognized as a deduction from equity. The proceeds from the exercise of stock options or warrants together with amounts previously recorded in reserves over the vesting periods are recorded as share capital. Income tax relating to transaction costs of an equity transaction is accounted for in accordance with Accounting Standards Codification (ASC) 740,

Income Taxes

(a)

Authorized

The Company has the following classes of share capital, with each class having no par value:

(i)

Subordinate Voting Shares

The holders of the Subordinate Voting Shares are entitled to receive dividends which may be declared from time to time and are entitled to one vote per share at meetings of the Company’s shareholders. All Subordinate Voting Shares are ranked equally with regard to the Company’s residual assets. The Company is authorized to issue an unlimited number of no par value Subordinate Voting Shares. During the nine months ending September 30, 2020, the shareholders of the Company converted 252,440 Multiple Voting Shares into 25,244,000 Subordinate Voting Shares and 22,953 Super Voting Shares into 2,295,300 Subordinate Voting Shares.

(ii)

Multiple Voting Shares

Each Multiple Voting Share is entitled to 100 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares. At September 30, 2020, the Company had 120,910 issued and outstanding Multiple Voting Shares, which convert into 12,091,000 Subordinate Voting Shares. The Company is authorized to issue an unlimited number of Multiple Voting Shares. During the nine months ending September 30, 2020, the shareholders of the Company converted 252,440 Multiple Voting Shares into 25,244,000 Subordinate Voting Shares.

(iii)

Super Voting Shares

Each Super Voting Share is entitled to 1,000 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares or one Multiple Voting Share. At September 30, 2020, the Company had 379,336 issued and outstanding Super Voting Shares which convert into 37,933,600 Subordinate Voting Shares. The Company is authorized to issue an unlimited number of Super Voting Shares. During the nine months ending September 30, 2020, the shareholders of the Company converted 22,953 Super Voting Shares into 2,295,300 Subordinate Voting Shares.

(b)

Issued and Outstanding

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:


	Issued and Outstanding
	Subordinate Voting Shares		Multiple Voting Shares			Super Voting Shares
As at December 31, 2019		128,999,964		373,350			402,289
Issuance of shares under business combinations and investments		238,450		—			—
Distribution of contingent consideration		2,713,463		—			—
Distribution of deferred shares		1,220,548		—			—
Issuance of shares for redemption of noncontrolling interests		1,315,789		—			—
Issuance of shares upon exercise of options and warrants		71,384		—			—
Issuances of shares upon vesting of RSUs		901,023		—			—
Exchange of shares		27,539,300		(252,440	)		(22,953	)

As at September 30, 2020		162,999,921		120,910			379,336

Issuance of Shares Under Business Combinations and Investments

MC Brands, LLC

On June 29, 2020, the Company issued

190,000 Subordinate Voting Shares with a value of $1,840,009

in connection with the Company’s June 27, 2019 acquisition of MC Brands, LLC. The shares issued resulted in an increase in share capital and a corresponding increase to intangible assets on the Company’s unaudited interim condensed consolidated balance sheets.

KW Ventures, LLC

On February 10, 2020, the Company issued 48,450 Subordinate Voting Shares which were issued at a value of $400,413 in connection with its January 1, 2019 acquisition of KW Ventures, LLC. Such shares were held back as part of the transaction and resulted in an increase in share capital and a reduction in accrued liabilities.

GTI New Jersey, LLC

In connection with the Company’s April 23, 2019 acquisition of the non-controlling interest in GTI New Jersey, LLC, the Company agreed to award the previous minority shareholders of the entity up to $3,000,000 in Subordinate Voting Shares. On May 7, 2020, the Company received approval from the New Jersey Department of Health to begin buildout of an additional retail dispensary. As a result, the Company recorded a current obligation and corresponding reduction to contributed surplus of $2,000,000 representing the maximum value of the shares to be issuable to the former minority shareholders of GTI New Jersey, LLC.

Distribution of Contingent Consideration

As of September 30, 2020, the Company issued 2,713,463 Subordinate Voting Shares to the previous owners of several entities in connection with acquisitions completed during 2019. Upon issuance, the Company recorded a reduction to contingent consideration payable and an increase in share capital. The following table represents the contingent shares issued as of September 30, 2020 in relation to each acquisition:

Contingent

Shares Issued


		September 30, 2020
Transaction	Date of Transaction	Units		Value

Advanced Grow Labs, LLC	February 12, 2019		1,396,533	$	11,544,855
For Success Holdings Company	February 21, 2019		779,690		6,686,432
Integral Associates, LLC	June 5, 2019		537,240		4,654,526

			2,713,463	$	22,885,813

Distribution of Deferred Shares

As a result of several acquisitions that occurred during 2019, the Company held 1,367,643 deferred shares with a value of $16,587,798 as of December 31, 2019. The deferred shares were to be issued upon the passage

of twelve to twenty-four

months from the close of each transaction as defined within each respective acquisition agreement. On May 15, 2020, Green Thumb issued 101,695 Subordinate Voting Shares with a value of $1,307,798 in connection with the Company’s May 15, 2019 acquisition of Salveo. On August 12, 2020, the Company issued 472,500 Subordinate Voting Shares with a value of $5,380,00 in connection with the Company’s February 12, 2019 acquisition of Advanced Grow Labs, LLC. Additionally, on August 26, 2020, the Company issued 646,353 Subordinate Voting Shares with a value of $8,064,668 in connection with the Company’s February 21, 2019 acquisition of For Success Holdings Company. The three distributions discussed above resulted in a reduction to deferred share issuances and a corresponding increase to share capital on the Company’s unaudited interim condensed consolidated statement of changes in shareholders’ equity.

(c)

Stock-Based Compensation

The Company operates equity settled stock-based remuneration plans for its eligible directors, officers, employees and consultants. All goods and services received in exchange for the grant of any stock-based payments are measured at their fair value unless the fair value cannot be estimated reliably. If the Company cannot estimate reliably the fair value of the goods and services received, the Company measures their value indirectly by reference to the fair value of the equity instruments granted. For transactions with employees and others providing similar services, the Company measures the fair value of the services by reference to the fair value of the equity instruments granted. Equity settled stock-based payments under stock-based payment plans are ultimately recognized as an expense in profit or loss with a corresponding credit to equity.

In June 2018, the Company established the Green Thumb Industries Inc. 2018 Stock and Incentive Plan, which was amended by Amendment No. 1 thereto (as amended, the “Plan”). The maximum number of Restricted Stock Units (“RSUs”) and options issued under the Plan shall not exceed

10%

of the issued and outstanding shares on an as-converted basis.

The Company recognizes compensation expense for RSUs and options on a straight-line basis over the requisite service period of the award. Non-market vesting conditions are included in the assumptions about the number of options that are expected to become exercisable. Estimates are subsequently revised if there is any indication that the number of share options expected to vest differs from the previous estimate. Any cumulative adjustment prior to vesting is recognized in the current period with no adjustment to prior periods for expense previously recognized.

Option and RSU grants generally vest over three years, and options typically have a life of five or ten years. Option grants are determined by the Compensation Committee of the Company’s Board of Directors with the option price set at no less than 100% of the fair market value of a share on the date of grant.

Stock

option activity is summarized as follows:


	Number of Shares			Weighted Average Exercise Price (CAD)		Weighted Average Contractual Life (Years)		Aggregate Intrinsic Value
Balance as at December 31, 2019		3,839,017			13.21		5.81	$	218,234
Granted		2,496,511			9.76		5.00
Exercised		(65,443	)		11.02		3.98
Forfeited		(487,486	)		13.82		5.22

Balance as at September 30, 2020		5,782,599			11.69		5.53
Vested		1,635,030			13.36		6.65
Exercisable at September 30, 2020		1,516,872			13.22		6.73	$	4,601,129

The aggregate intrinsic value in the table above represents the total

pre-tax

intrinsic value (the difference between the Company’s closing stock price on September 30, 2020 and December 31, 2019, respectively, and the exercise price, multiplied by the number of

in-the-money

options) that would have been received by the option holders had all option holders exercised their

in-the-money

options on September 30, 2020 and December 31, 2019. This amount will change in future periods based on the fair market value of the Company’s Subordinate Voting Shares and the number of options outstanding.

The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted during the nine months ended September 30, 2020, using the following ranges of assumptions:


Risk-free interest rate			0.36% - 2.33%
Expected dividend yield			0%
Expected volatility			80% - 100%
Expected option life			3 – 10 years

As the Company became publicly traded in June 2018, sufficient historical trading information was not available to determine an expected volatility rate. The volatility rate was based on comparable companies within the same industry. As permitted under ASC 718, the Company has made an accounting policy choice to account for forfeitures when they occur.

The following table summarizes the number of

non-vested

RSU awards as of September 30, 2020 and December 31, 2019 and the changes during the nine months ended September 30, 2020:


	Number of Shares			Weighted Average Grant Date Fair Value (CAD)
Nonvested Shares at December 31, 2019		1,399,762			9.30
Granted		254,268			12,65
Forfeited		(64,500	)		15.60
Vested		(901,023	)		14.85

Nonvested Shares at September 30, 2020		688,507			16.77

The stock-based compensation expense for the three and nine months ended September 30, 2020 and 2019 was as followed:


	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Stock options expense	$	2,614,273	$	1,666,465	$	8,209,557	$	4,248,461
RSUs		1,821,054		1,897,630		6,999,963		9,075,622

Total Stock Based Compensation Expense	$	4,435,634	$	3,564,095	$	15,209,520	$	13,324,083

As of September 30, 2020, $25,815,117 of total unrecognized expense related to Stock Based Compensation awards is expected to be recognized over a weighted-average period of 1.93 years.

(

)

Issuance of Shares for Redemption of Noncontrolling Interest

On August 8, 2020, the Company and its joint venture partner in Ohio Investors 2017, LLC reached an agreement allowing Green Thumb to purchase the remaining noncontrolling interest in Ohio Investors 2017, LLC from the partner. As a result, on August 31, 2020, the Company

issued 1,315,789 Subordinate Voting Shares with a value of $20,078,940 in consideration for the noncontrolling partner’s interest in Ohio Investors 2017, LLC. Upon the closing of the transaction, the Company recorded a reduction to the current liability established for the purchase of the noncontrolling interest of $11,200,000, an increase in share capital for the fair value of the noncontrolling partners interest of $20,078,940 and a reduction to contributed capital of $8,878,940.

Other Income (Expense)

9 Months Ended

Sep. 30, 2020

Other Income and Expenses [Abstract]

Other Income (Expense)

11.	OTHER INCOME (EXPENSE)

For the three and nine months ended September 30, 2020 and 2019 other income (expense) was comprised of the following:


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2020			2019			2020			2019

Fair value adjustments on equity investments	$	8,134,213		$	(1,196,676	)	$	8,117,178		$	(932,983	)
Fair value adjustments on variable note receivable		—			(5,428,542	)		(815,937	)		(7,424,727	)
Fair value adjustments on warrants issued		(3,181,114	)		—			(2,060,771	)		—
Fair value adjustments on contingent consideration		442,991			—			425,426			—
Other		1,036,793			39,678			1,835,670			388,277


Total Other Income (Expense)	$	6,432,883		$	(6,585,540	)	$	7,501,566		$	(7,969,433	)

Commitments and Contingencies

9 Months Ended

Sep. 30, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

12.	COMMITMENTS AND CONTINGENCIES

The Company is subject to lawsuits, investigations and other claims related to employment, commercial and other matters that arise out of operations in the normal course of business. Periodically, the Company reviews the status of each significant matter and assesses the potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable, and the amount can be reliably estimated, such amount is recognized in other liabilities.

Contingent liabilities are measured at management’s best estimate of the expenditure required to settle the obligation at the end of the reporting period and are discounted to present value where the effect is material. The Company performs evaluations to identify contingent liabilities for contracts. Contingent consideration is measured upon acquisition and is estimated using probability weighting of potential payouts. Subsequent changes in the estimated contingent consideration from the final purchase price allocation are recognized in the Company’s unaudited interim condensed consolidated statement of operations.

(a)

Contingencies

The Company’s operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, sanctions, restrictions on its operations, or losses of permits that could result in the Company ceasing operations in that specific state or local jurisdiction. While management believes that the Company is in compliance with applicable local and state regulations at September 30, 2020 and December 31, 2019, cannabis and other regulations continue to evolve and are subject to differing interpretations. As a result, the Company may be subject to regulatory fines, penalties, or restrictions in the future.

(b)

Claims and Litigation

From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. At September 30, 2020 and December 31, 2019, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company’s consolidated operations. There are also no proceedings in which any of the Company’s directors, officers or affiliates is an adverse party or has a material interest adverse to the Company’s interest.

(c)

Construction Commitments

As of September 30, 2020, the Company held approximately $25,600,000 of open commitments to contractors primarily associated with improvements being made to one of the Company’s cultivation and processing facilities. The Company expects to be reimbursed for approximately $22,500,000 of the open commitment as part of its sale and lease back agreement with IIP.

Fair Value Measurements

9 Months Ended

Sep. 30, 2020

Disclosure Text Block Supplement [Abstract]

Fair Value Measurements

13.	FAIR VALUE MEASUREMENTS

The Company applies fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities that are required to be recorded at fair value, the Company considers all related factors of the asset by market participants in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions, and credit risk.

The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into

three

levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1

– Unadjusted quoted prices in active markets for identical assets or liabilities;

Level 2

– Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly; and

Level 3

– Inputs for the asset or liability that are not based on observable market data.

Financial

Instruments

The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, notes receivable, due from related parties, investments, accounts payable and accrued liabilities, notes payable, derivative liability, liability for acquisition of noncontrolling interest and contingent consideration payable.

Financial instruments recorded at fair value are classified using a fair value hierarchy that reflects the significance of the inputs to fair value measurements. The fair values of the Company’s financial instruments associated with each of the three levels of the hierarchy are:


	As of September 30, 2020
	Level 1		Level 2		Level 3			Total

Cash and Cash Equivalents	$	78,091,073	$	—	$	—		$	78,091,073
Investments		675,594		—		21,535,406			22,210,999
Liability of Redemption of Noncontrolling Interest		—		—		—			—
Contingent Consideration Payable		—		—		(36,315,360	)		(36,315,360	)
Warrant Liability		—		—		(18,513,000	)		(18,513,000	)

	$	78,766,667	$	—	$	(33,292,954	)	$	45,473,712



	As of December 31, 2019
	Level 1		Level 2		Level 3			Total

Cash and Cash Equivalents	$	46,667,334	$	—	$	—		$	46,667,334
Notes Receivable		—		—		815,937			815,937
Investments		—		—		14,068,821			14,068,821
Liability of Redemption of Noncontrolling Interest		—		—		(5,500,000	)		(5,500,000	)
Contingent Consideration Payable		—		—		(58,936,739	)		(58,936,739	)
Warrant Liability		—		—		(15,879,843	)		(15,879,843	)

	$	46,667,334	$	—	$	(65,431,824	)	$	(18,764,490	)

As of December 31, 2019, the Company held an equity investment in a privately held entity that was subsequently acquired by a publicly traded entity during the third quarter of 2020. As a result of the acquisition, the Company received shares of the acquiring entity in exchange for the shares in the privately held entity. Further, the transaction resulted in a transfer of the investment from Level

3 to Level 1. As of September 30, 2020, the value of the Level 1 investment was

$675,594.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Variable Interest Entities

9 Months Ended

Sep. 30, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Variable Interest Entities

14.	VARIABLE INTEREST ENTITIES

The following table presents the summarized financial information about the Company’s consolidated variable interest entities (“VIEs”) which are included in the unaudited interim condensed consolidated balance sheets as of September 30, 2020 and December 31, 2019:


	September 30, 2020						December 31, 2019
	Chesapeake Alternatives, LLC		Illinois Disp, LLC		Other Non-material VIEs		Chesapeake Alternatives, LLC		Illinois Disp, LLC		Other Non-material VIEs
Current assets	$	29,728,652	$	2,489,118	$	2,261,685	$	19,455,533	$	1,381,716	$	1,352,935
Non-current assets		3,041,401		3,752,645		2,353,991		22,384,663		3,083,659		2,534,297
Current liabilities		21,228,691		898,661		1,108,292		14,219,204		149,498		783,682
Non-current liabilities		785,724		473,136		802,823		1,169,989		137,736		855,440
Equity attributable to noncontrolling interests		298,252		2,309,983		85,561		350,206		2,089,071		(22,488	)
Equity attributable to Green Thumb Industries Inc.		10,457,386		2,309,983		2,619,001		6,645,263		2,089,070		2,270,598

The Following tables presents the summarized financial information about the Company’s VIEs which are included in the unaudited interim condensed consolidated statements of operations for the three and nine months ended September 30, 2020 and 2019:


	Three Months Ended
	September 30, 2020						September 30, 2019
	Chesapeake Alternatives, LLC		Illinois Disp, LLC		Other Non-material VIEs		Chesapeake Alternatives, LLC			Illinois Disp, LLC		Other Non-material VIEs
Revenues	$	5,684,349	$	5,224,583	$	2,695,781	$	4,369,436		$	1,620,065	$	689,097
Net income (loss) attributable to noncontrolling interests		26,134		897,494		185,452		1,807,394			185,930		(1,624,850	)
Net income (loss) attributable to Green Thumb Industries Inc.		1,033,650		897,494		294,969		(971,880	)		185,931		1,059,653


Net income (loss)	$	1,059,784	$	1,794,988	$	480,421	$	835,514		$	371,860	$	(565,197	)


	Nine Months Ended
	September 30, 2020						September 30, 2019
	Chesapeake Alternatives, LLC		Illinois Disp, LLC		Other Non-material VIEs		Chesapeake Alternatives, LLC		Illinois Disp, LLC		Other Non-material VIEs
Revenues	$	14,792,710	$	13,170,514	$	6,778,501	$	12,458,427	$	4,174,045	$	2,373,042
Net income (loss) attributable to noncontrolling interests		206,929		2,170,912		319,511		2,244,546		506,972		(2,307,097	)
Net income (loss) attributable to Green Thumb Industries Inc.		3,812,121		2,170,913		661,341		—		506,972		—


Net income (loss)	$	4,019,050	$	4,341,825	$	980,852	$	2,244,546	$	1,013,943	$	(2,307,097	)

As of September 30, 2020, and December 31, 2019, VIEs included in the Other

Non-material

VIEs are Bluepoint Wellness of Westport LLC and Meshow, LLC. As of September 30, 2019, VIEs included in the Other

Non-material

VIEs are Meshow, LLC, KW Ventures Holdings, LLC and Ohio Investors 2017, LLC. All of these entities were determined to be VIEs as the Company possesses the power to direct activities through management services agreements.

Segment Reporting

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Segment Reporting

15.	SEGMENT REPORTING

The Company operates in two segments: the cultivation, production and sale of cannabis products to retail stores (“Consumer Packaged Goods”) and retailing of cannabis to patients and consumers (“Retail”). The Company does not allocate operating expenses to these business units, nor does it allocate specific assets. Additionally, the Chief Operating Decision Maker does not review total assets or net income (loss) by segments; therefore, such information is not presented below.

The below table presents revenues by type for the three and nine months ended September 30, 2020 and 2019:


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020			2019			2020			2019
Revenues, Net of Discounts
Consumer Packaged Goods	$	74,702,069		$	35,093,858		$	177,355,614		$	71,651,968
Retail		111,948,115			43,532,286			275,451,137			85,501,646
Intersegment Eliminations		(29,546,343	)		(10,635,237	)		(73,460,384	)		(16,522,767	)

Total Revenues, net of discounts	$	157,103,841		$	67,990,907		$	379,346,367		$	140,630,847

Depreciation and Amortization
Consumer Packaged Goods	$	10,029,857		$	7,226,614		$	33,089,808		$	16,100,635
Retail		1,505,019			687,199			5,309,152			1,428,256
Intersegment Eliminations		—			—			—			—

Total Depreciation and Amortization	$	11,534,876		$	7,913,813		$	38,479,960		$	17,528,891

Income Taxes
Consumer Packaged Goods	$	12,928,449		$	1,072,333		$	23,553,449		$	1,761,333
Retail		15,507.883			5,128,000			33,410,598			9,028,000
Intersegment Eliminations and Corporate		—			(2,576,000	)		—			(6,083,333	)

Total Income Taxes	$	28,436,332		$	3,624,333		$	56,964,047		$	4,706,000

Goodwill assigned to the Consumer Packaged Goods segment as of September 30, 2020 and December 31, 2019 was $252,016,532 and $255,211,232, respectively. Intangible assets, net assigned to the Consumer Packaged Goods segment as of September 30, 2020 and December 31, 2019 was $215,986,854 and $228,244,254, respectively.

Goodwill assigned to the Retail segment as of September 30, 2020 and December 31, 2019 was $121,065,184 and $119,873,759, respectively. Intangible assets, net assigned to the Retail segment as of September 30, 2020 and December 31, 2019 was $193,668,663 and $207,002,644, respectively.

The Company’s assets are aggregated into two reportable segments (Retail and Consumer Packaged Goods). For the purposes of testing goodwill, Green Thumb has identified 22 reporting units. The Company determined its reporting units by first reviewing the operating segments based on the geographic areas in which Green Thumb conducts business (or each market). The markets were then further divided into reporting units based on the market operations (Retail and Consumer Packaged Goods) which were primarily determined based on the licenses each market holds. All revenues are derived from customers domiciled in the United States and all assets are located in the United States.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

Overview and Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Basis of Accounting

(b)

Basis of Presentation

The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the entire year ending December 31, 2020.

Significant Accounting Policies

(c)

Significant Accounting Policies

There have been no changes to the Company’s significant accounting policies as described in Note 2 of the Company’s 2019 Form 10-K.

Earnings (Loss) per Share

(d)

Earnings (Loss) per Share

New Accounting Pronouncements

(e)

Recently Adopted Accounting Standards

(i)

(ii)

(iii)

(f)

Recently Issued Accounting Standards

(i)

(ii)

(iii)

On August 5, 2020, the FASB issued Accounting Standards Update No. 2020-06,

Intangible Assets and Goodwill

At September 30, 2020 intangible assets consisted of the following:


	Licenses and Permits			Tradenames		Customer Relationships		Non-Competition Agreements		Total
Cost
As at January 1, 2020	$	336,954,213		$	97,455,590	$	25,258,000	$	2,585,480	$	462,253,283
Adjustments to Purchase Price Allocation		(145,000	)		1,840,009		—		—		1,695,009

As at September 30, 2020	$	336,809,213		$	99,295,599	$	25,258,000	$	2,585,480	$	463,948,292

Accumulated Amortization
As at January 1, 2020	$	18,477,500		$	4,121,800	$	3,932,416	$	474,669	$	27,006,385
Amortization		17,701,556			6,412,282		2,777,802		394,750		27,286,390

As at September 30, 2020	$	36,179,056		$	10,534,082	$	6,710,218	$	869,419	$	54,292,775

Net book value
As at January 1, 2020	$	318,476,713		$	93,333,790	$	21,325,584	$	2,110,811	$	435,246,898
As at September 30, 2020	$	300,630,157		$	88,761,517	$	18,547,782	$	1,716,061	$	409,655,517

At December 31, 2019 intangible assets consisted of the following:


	Licenses and Permits		Tradenames		Customer Relationships		Non-Competition Agreements		Total
Cost
As at January 1, 2019	$	89,705,213	$	360,000	$	820,000	$	20,480	$	90,905,693
Additions from acquisitions		247,249,000		97,095,590		24,438,000		2,565,000		371,347,590

As at December 31, 2019	$	336,954,213	$	97,455,590	$	25,258,000	$	2,585,480	$	462,253,283

Accumulated Amortization
As at January 1, 2019	$	2,322,715	$	—	$	204,500	$	12,800	$	2,540,015
Amortization		16,154,785		4,121,800		3,727,916		461,869		24,466,370

As at December 31, 2019	$	18,477,500	$	4,121,800	$	3,932,416	$	474,669	$	27,006,385

Net book value
As at January 1, 2019	$	87,382,498	$	360,000	$	615,500	$	7,680	$	88,365,678
As at December 31, 2019	$	318,476,713	$	93,333,790	$	21,325,584	$	2,110,811	$	435,246,898


Year Ending December 31,	Estimated Amortization (Prior to Change in Useful Life)		Increase (Decrease) from Change in Useful Life			Estimated Amortization (After Change in Useful Life)
Remainder of 2020	$	8,426,261	$	1,266,880		$	9,693,141
2021		33,705,044		5,067,520			38,772,564
2022		33,274,305		5,067,520			38,341,825
2023		33,191,489		5,067,520			38,259,009
2024		32,610,156		5,067,520			37,677,676
Thereafter		268,448,262		(21,536,960	)		246,911,302

	$	409,655,517	$	—		$	409,655,517

Goodwill

At September 30, 2020, Goodwill consisted of the following:


	Retail		Consumer Packaged Goods			Total
As at January 1, 2020	$	119,873,759	$	255,211,232		$	375,084,991
Adjustments to Purchase Price Allocations		1,191,425		(3,194,700	)		(2,003,275	)

As at September 30, 2020	$	121,065,184	$	252,016,532		$	373,081,716

At December 31, 2019, Goodwill consisted of the following:


	Retail		Consumer Packaged Goods			Total
As at January 1, 2019	$	15,286,360	$	23,918,000		$	39,204,360
Acquisition of Advanced Grow Labs, LLC		16,756,250		44,572,349			61,328,599
Acquisition of Integral Associates, LLC		46,655,753		69,323,570			115,979,323
Other Acquisitions		32,936,590		120,963,598			153,900,188
Adjustments to Purchase Price Allocations		8,238,808		(3,566,285	)		4,672,523

As at December 31, 2019	$	119,873,759	$	255,211,232		$	375,084,991

During the nine months ended September 30, 2020, the Company recorded measurement period adjustments resulting in a net decrease in goodwill of $2,003,275 associated

with

Fair Value Measurement

The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into

three

levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1

– Unadjusted quoted prices in active markets for identical assets or liabilities;

Level 2

– Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly; and

Level 3

– Inputs for the asset or liability that are not based on observable market data.

Financial Instruments

Financial

Instruments


	As of September 30, 2020
	Level 1		Level 2		Level 3			Total

Cash and Cash Equivalents	$	78,091,073	$	—	$	—		$	78,091,073
Investments		675,594		—		21,535,406			22,210,999
Liability of Redemption of Noncontrolling Interest		—		—		—			—
Contingent Consideration Payable		—		—		(36,315,360	)		(36,315,360	)
Warrant Liability		—		—		(18,513,000	)		(18,513,000	)

	$	78,766,667	$	—	$	(33,292,954	)	$	45,473,712



	As of December 31, 2019
	Level 1		Level 2		Level 3			Total

Cash and Cash Equivalents	$	46,667,334	$	—	$	—		$	46,667,334
Notes Receivable		—		—		815,937			815,937
Investments		—		—		14,068,821			14,068,821
Liability of Redemption of Noncontrolling Interest		—		—		(5,500,000	)		(5,500,000	)
Contingent Consideration Payable		—		—		(58,936,739	)		(58,936,739	)
Warrant Liability		—		—		(15,879,843	)		(15,879,843	)

	$	46,667,334	$	—	$	(65,431,824	)	$	(18,764,490	)

3 to Level 1. As of September 30, 2020, the value of the Level 1 investment was

$675,594.

Inventories (Tables)

9 Months Ended

Sep. 30, 2020

Inventory Disclosure [Abstract]

Summary of inventory

The Company’s inventories include the following at September 30, 2020 and December 31, 2019:


	September 30,			December 31,
	2020			2019
Raw Material	$	3,603,977		$	6,375,032
Packaging and Miscellaneous		6,173,017			4,887,970
Work in Process		24,945,006			20,162,723
Finished Goods		22,430,016			16,640,629
Reserve for Obsolete Inventory		(1,987,758	)		(2,031,873	)


Total Inventories	$	55,164,258		$	46,034,481

Property and Equipment (Tables)

9 Months Ended

Sep. 30, 2020

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

At September 30, 2020, property and equipment consisted of the following:


Cost	Land			Buildings and Improvements			Equipment, Computers and Furniture		Leasehold Improvements		Capitalized Interest		Assets Under Construction			Total
As at January 1, 2020	$	3,272,439		$	33,377,471		$	35,509,871	$	68,681,497	$	2,500,000	$	21,372,116		$	164,713,394
Additions		586.867			21,128,482			4,794,342		12,413,970		342,966		6,118,878			45,385,505
Disposals		(979,930	)		(4,507,086	)		—		—		—		(6,978,389	)		(12,465,405	)

As at September 30, 2020	$	2,879,376		$	49,998,867		$	40,304,213	$	81,095,467	$	2,842,966	$	20,512,605		$	197,633,494


Accumulated Depreciation
As at January 1, 2020	$	—		$	2,236,254		$	3,882,178	$	2,998,287	$	—	$	—		$	9,116,719
As at September 30, 2020	$	—		$	2,939,951		$	8,375,318	$	8,426,333	$	166,800	$	—		$	19,908,402

Net book value
As at January 1, 2020	$	3,272,439		$	31,141,217		$	31,627,693	$	65,683,210	$	2,500,000	$	21,372,116		$	155,596,675
As at September 30, 2020	$	2,879,376		$	47,058,916		$	31,928,895	$	72,669,134	$	2,676,166	$	20,512,605		$	177,725,092

At December 31, 2019, property and equipment consisted of the following:


Cost	Land			Buildings and Improvements			Equipment, Computers and Furniture			Leasehold Improvements		Capitalized Interest		Assets Under Construction		Total
As at January 1, 2019	$	2,243,085		$	20,861,988		$	11,001,498		$	18,435,893	$	—	$	16,664,958	$	69,207,422
Additions		4,393,030			28,217,500			23,109,209			38,002,678		2,500,000		4,678,084		100,900,501
Additions from acquisitions		—			—			4,253,362			12,242,926		—		29,074		16,525,362
Disposals		(3,363,676	)		(15,702,017	)	$	(2,854,198	)		—		—		—		(21,919,891	)

As at December 31, 2019	$	3,272,439		$	33,377,471		$	35,509,871		$	68,681,497	$	2,500,000	$	21,372,116	$	164,713,394


Accumulated Depreciation
As at January 1, 2019	$	—		$	1,351,230		$	1,524,114		$	1,007,998	$	—	$	—	$	3,883,342
As at December 31, 2019	$	—		$	2,236,254		$	3,882,178		$	2,998,287	$	—	$	—	$	9,116,719

Net book value
As at January 1, 2019	$	2,243,085		$	19,510,758		$	9,477,384		$	17,427,895	$	—	$	16,664,958	$	65,324,080
As at December 31, 2019	$	3,272,439		$	31,141,217		$	31,627,693		$	65,683,210	$	2,500,000	$	21,372,116	$	155,596,675

Intangible Assets And Goodwill (Tables)

9 Months Ended

Sep. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of intangible assets

At September 30, 2020 intangible assets consisted of the following:


	Licenses and Permits			Tradenames		Customer Relationships		Non-Competition Agreements		Total
Cost
As at January 1, 2020	$	336,954,213		$	97,455,590	$	25,258,000	$	2,585,480	$	462,253,283
Adjustments to Purchase Price Allocation		(145,000	)		1,840,009		—		—		1,695,009

As at September 30, 2020	$	336,809,213		$	99,295,599	$	25,258,000	$	2,585,480	$	463,948,292

Accumulated Amortization
As at January 1, 2020	$	18,477,500		$	4,121,800	$	3,932,416	$	474,669	$	27,006,385
Amortization		17,701,556			6,412,282		2,777,802		394,750		27,286,390

As at September 30, 2020	$	36,179,056		$	10,534,082	$	6,710,218	$	869,419	$	54,292,775

Net book value
As at January 1, 2020	$	318,476,713		$	93,333,790	$	21,325,584	$	2,110,811	$	435,246,898
As at September 30, 2020	$	300,630,157		$	88,761,517	$	18,547,782	$	1,716,061	$	409,655,517

At December 31, 2019 intangible assets consisted of the following:


	Licenses and Permits		Tradenames		Customer Relationships		Non-Competition Agreements		Total
Cost
As at January 1, 2019	$	89,705,213	$	360,000	$	820,000	$	20,480	$	90,905,693
Additions from acquisitions		247,249,000		97,095,590		24,438,000		2,565,000		371,347,590

As at December 31, 2019	$	336,954,213	$	97,455,590	$	25,258,000	$	2,585,480	$	462,253,283

Accumulated Amortization
As at January 1, 2019	$	2,322,715	$	—	$	204,500	$	12,800	$	2,540,015
Amortization		16,154,785		4,121,800		3,727,916		461,869		24,466,370

As at December 31, 2019	$	18,477,500	$	4,121,800	$	3,932,416	$	474,669	$	27,006,385

Net book value
As at January 1, 2019	$	87,382,498	$	360,000	$	615,500	$	7,680	$	88,365,678
As at December 31, 2019	$	318,476,713	$	93,333,790	$	21,325,584	$	2,110,811	$	435,246,898

Summary of estimated annual amortization expense related to intangible assets


Year Ending December 31,	Estimated Amortization (Prior to Change in Useful Life)		Increase (Decrease) from Change in Useful Life			Estimated Amortization (After Change in Useful Life)
Remainder of 2020	$	8,426,261	$	1,266,880		$	9,693,141
2021		33,705,044		5,067,520			38,772,564
2022		33,274,305		5,067,520			38,341,825
2023		33,191,489		5,067,520			38,259,009
2024		32,610,156		5,067,520			37,677,676
Thereafter		268,448,262		(21,536,960	)		246,911,302

	$	409,655,517	$	—		$	409,655,517

Summary of Goodwill And Intangible Assets Disclosure

At September 30, 2020, Goodwill consisted of the following:


	Retail		Consumer Packaged Goods			Total
As at January 1, 2020	$	119,873,759	$	255,211,232		$	375,084,991
Adjustments to Purchase Price Allocations		1,191,425		(3,194,700	)		(2,003,275	)

As at September 30, 2020	$	121,065,184	$	252,016,532		$	373,081,716

At December 31, 2019, Goodwill consisted of the following:


	Retail		Consumer Packaged Goods			Total
As at January 1, 2019	$	15,286,360	$	23,918,000		$	39,204,360
Acquisition of Advanced Grow Labs, LLC		16,756,250		44,572,349			61,328,599
Acquisition of Integral Associates, LLC		46,655,753		69,323,570			115,979,323
Other Acquisitions		32,936,590		120,963,598			153,900,188
Adjustments to Purchase Price Allocations		8,238,808		(3,566,285	)		4,672,523

As at December 31, 2019	$	119,873,759	$	255,211,232		$	375,084,991

Leases (Table)

9 Months Ended

Sep. 30, 2020

Leases [Abstract]

Schedule Of Other Information Related To Operating Leases

Other information related to operating leases as of and for the three and nine months ending September 30, 2020 were as follows:


	As of September 30, 2020
Weighted average remaining lease term		10.81
Weighted average discount rate		13.2	%

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

Maturities of lease liabilities for operating leases as of September 30, 2020 were as follows:


	Maturities of Lease Liability
	Third Party			Related Party			Total
Remainder of 2020	$	4,767,957		$	322,287		$	5,090,244
2021		22,243,662			1,307,183			23,550,845
2022		22,285,836			1,337,130			23,622,966
2023		22,092,882			1,367,771			23,460,653
2024		21,387,294			1,255,714			22,643,008
2025 and Thereafter		183,998,689			10,345,330			194,344,019

Total Lease Payments		276,776,320			15,935,415			292,711,735

Less: Interest		(177,811,636	)		(7,837,605	)		(185,649,241	)

Present Value of Lease Liability	$	98,964,684		$	8,907,810		$	107,062,494

Notes Payable (Tables)

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Schedule of Debt

At September 30, 2020 and December 31, 2019, notes payable consisted of the following:


	September 30, 2020			December 31, 2019

In connection with an acquisition completed in 2017, the Company is required to make quarterly charitable contributions of $50,000 through October 2024. The net present value of these required payments has been recorded as a liability with an interest rate of 2.17%.	$	763,284		$	970,957

Private placement debt dated May 22, 2019, in the original amount of $105,466,429 with an interest rate of 12.00%, matures on May 22, 2023. The debt was issued at a discount, the carrying value of which is $11,618,400 as of September 30, 2020		93,848,029			90,375,912

Rise Joliet mortgage dated June 5, 2020, in the original amount of $1,814,000 with an interest rate of 5.00%, matures on June 5, 2035. The debt was issued at a discount, the carrying value of which is $177,244 as of September 30, 2020.		1,616,606			—

Rise Lakewood mortgage dated August 20, 2020, in the original amount of $833,000 with an interest rate of 7.25%, matures on August 20, 2025.		831,341			—

Total notes payable		97,059,260			91,346,869
Less: current portion of notes payable		(301,027	)		(206,675	)

Notes payable, net of current portion	$	96,758,233		$	91,140,194

Warrants (Tables)

9 Months Ended

Sep. 30, 2020

Class of Warrant or Right [Line Items]

Schedule of Stockholders' Equity Note, Warrants or Rights

The following table summarizes the number warrants outstanding as of September 30, 2020 and December 31, 2019:


	Number of Shares				Weighted Average Exercise Price (C$)		Weighted Average Contractual Life		Number of Shares		Weighted Average Exercise Price (USD)		Weighted Average Contractual Life
	Liability Classified								Equity Classified
Balance as at December 31, 2019		2,406,811		C$		18.59		4.86		-	$	-		-
Additional Modification Warrants		84,924				14.03		5.00		-		-		-
Dispensary Mortgage Warrants		-				-		-		35,000		9.10		5.00
Warrants Exercised		(5,941	)			12.42		5.00		-		-		-

Balance as at September 30, 2020		2,485,794		C$		18.45		4.87		35,000	$	9.10		5.00

Liability Classified Warrant [member]

Class of Warrant or Right [Line Items]

Schedule Of Fair Value Of Warrant Liability

The following table summarizes the fair value of the liability classified warrants at September 30, 2020 and December 31, 2019:


Warrant Liability	Strike Price		Warrants Outstanding		September 30, 2020		December 31, 2019
Bridge Financing Warrants	C$	22.90		218,964	$	1,065,000	$	1,385,400
Private Placement Financing Warrants	C$	19.39		1,822,771		13,457,000		12,189,169
Modification Warrants	C$	12.04		360,256		3,251,500		2,305,274
Additional Modification Warrants	C$	14.03		83,803		739,500		—

Totals				2,485,794	$	18,513,000	$	15,879,843

Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability

The following table summarizes the significant assumptions used in determining the fair value of the warrant liability as of each reporting date

ee Note 13 - Fair Value Measurements for additional details

)


Significant Assumptions	September 30, 2020		December 31, 2019
Volatility		85.36 % - 89.50 %		117.43 % - 123.64 %
Remaining Term		2.03 - 4.64 years		2.78 - 4.86 years
Risk Free Rate		0.25 % - 0.34 %		1.68% - 1.69 %

Equity Classified Warrant [member]

Class of Warrant or Right [Line Items]

Schedule Of Fair Value Of Warrant Liability

The following table summarizes the fair value of the equity classified warrants at September 30, 2020 and December 31, 2019:


Warrants Included in Contributed Surplus	Strike Price		Warrants Outstanding		September 30, 2020		December 31, 2019
Dispensary Mortgage Warrants	$	9.10		35,000	$	181,272	$	—

Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability

The following table summarizes the significant assumptions used in determining the fair value of the equity classified warrants as of each reporting date:


Significant Assumptions	September 30, 2020			December 31, 2019
Volatility		80	%		—
Remaining Term		5 years			—
Risk Free Rate		0.37	%		—

Additional Modifications Warrants [member]

Class of Warrant or Right [Line Items]

Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability


Significant Assumptions	May 21, 2020 (Date of Issuance)
Volatility		100	%
Remaining Term		5 years
Risk Free Rate		0.42	%

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2020

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)

The following table summarizes the Company’s income tax expense and effective tax rates for the three and nine months ended September 30, 2020 and September 30, 2019:


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020			2019			2020			2019
Income/(Loss) before Income Taxes	$	39,189,341		$	(10,713,603	)	$	52,189,559			(40,011,094	)
Income Tax Expense	$	28,436,332		$	3,624,333		$	56,964,047			4,706,000
Effective Tax Rate		72.6	%		-33.8	%		109.1	%		-11.8	%

Investments (Tables)

9 Months Ended

Sep. 30, 2020

Schedule of Investments [Line Items]

Schedule Of Long Term Investments


	Convertible Notes Receivable			Equity		Total
Balance at January 1, 2020	$	7,533,000		$	6,535,821	$	14,068,821
Additions		—			25,000		25,000
Conversion of notes receivable		(7,533,000	)		7,533,000		—
Fair value adjustment		—			8,117,178		8,117,178

Balance at September 30, 2020	$	—		$	22,210,999	$	22,210,999

The following table summarizes the change in the Company’s investments as of December 31, 2019:


	Convertible Notes Receivable			Equity			Total
Balance at January 1, 2019	$	30,336,000		$	10,597,283		$	40,933,283
Fair value adjustment		(1,398,000	)		(4,061,462	)		(5,459,462	)
Applied to consideration in business combination		(21,405,000	)		—			(21,405,000	)

Balance at December 31, 2019	$	7,533,000		$	6,535,821		$	14,068,821

Schedule Of Fair Value Measurement Inputs and Valuation Techniques


		December 31, 2019
Risk free rate		1.58% -2.46%
Equity Volatility		58% - 106%
Market Yield		15% - 18%
Probability of Qualified Financing		0%
Probability of Sale		30%
Probability of No Event		70%

Equity Method Investments [Member]

Schedule of Investments [Line Items]

Schedule Of Fair Value Measurement Inputs and Valuation Techniques


		September 30, 2020
Discount for lack of control		13%
Discount for lack of marketability		10%-30%

Share Capital (Tables)

9 Months Ended

Sep. 30, 2020

Disclosure of Share Capital [Line Items]

Schedule of Common Stock Outstanding Roll Forward

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:


	Issued and Outstanding
	Subordinate Voting Shares		Multiple Voting Shares			Super Voting Shares
As at December 31, 2019		128,999,964		373,350			402,289
Issuance of shares under business combinations and investments		238,450		—			—
Distribution of contingent consideration		2,713,463		—			—
Distribution of deferred shares		1,220,548		—			—
Issuance of shares for redemption of noncontrolling interests		1,315,789		—			—
Issuance of shares upon exercise of options and warrants		71,384		—			—
Issuances of shares upon vesting of RSUs		901,023		—			—
Exchange of shares		27,539,300		(252,440	)		(22,953	)

As at September 30, 2020		162,999,921		120,910			379,336

Schedule of Business Acquisitions of Contingent Consideration

The following table represents the contingent shares issued as of September 30, 2020 in relation to each acquisition:

Contingent

Shares Issued


		September 30, 2020
Transaction	Date of Transaction	Units		Value

Advanced Grow Labs, LLC	February 12, 2019		1,396,533	$	11,544,855
For Success Holdings Company	February 21, 2019		779,690		6,686,432
Integral Associates, LLC	June 5, 2019		537,240		4,654,526

			2,713,463	$	22,885,813

Share-based Payment Arrangement, Option, Activity

Stock

option activity is summarized as follows:


	Number of Shares			Weighted Average Exercise Price (CAD)		Weighted Average Contractual Life (Years)		Aggregate Intrinsic Value
Balance as at December 31, 2019		3,839,017			13.21		5.81	$	218,234
Granted		2,496,511			9.76		5.00
Exercised		(65,443	)		11.02		3.98
Forfeited		(487,486	)		13.82		5.22

Balance as at September 30, 2020		5,782,599			11.69		5.53
Vested		1,635,030			13.36		6.65
Exercisable at September 30, 2020		1,516,872			13.22		6.73	$	4,601,129

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted during the nine months ended September 30, 2020, using the following ranges of assumptions:


Risk-free interest rate			0.36% - 2.33%
Expected dividend yield			0%
Expected volatility			80% - 100%
Expected option life			3 – 10 years

Schedule of Stock-Based Compensation Expense

The stock-based compensation expense for the three and nine months ended September 30, 2020 and 2019 was as followed:


	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Stock options expense	$	2,614,273	$	1,666,465	$	8,209,557	$	4,248,461
RSUs		1,821,054		1,897,630		6,999,963		9,075,622

Total Stock Based Compensation Expense	$	4,435,634	$	3,564,095	$	15,209,520	$	13,324,083

Restricted Stock Units (RSUs) [member]

Disclosure of Share Capital [Line Items]

Non-vested Restricted Stock Shares Activity

The following table summarizes the number of

non-vested

RSU awards as of September 30, 2020 and December 31, 2019 and the changes during the nine months ended September 30, 2020:


	Number of Shares			Weighted Average Grant Date Fair Value (CAD)
Nonvested Shares at December 31, 2019		1,399,762			9.30
Granted		254,268			12,65
Forfeited		(64,500	)		15.60
Vested		(901,023	)		14.85

Nonvested Shares at September 30, 2020		688,507			16.77

Other Income (Expense) (Tables)

9 Months Ended

Sep. 30, 2020

Other Income and Expenses [Abstract]

Schedule of Other Nonoperating Income (Expense)

For the three and nine months ended September 30, 2020 and 2019 other income (expense) was comprised of the following:


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2020			2019			2020			2019

Fair value adjustments on equity investments	$	8,134,213		$	(1,196,676	)	$	8,117,178		$	(932,983	)
Fair value adjustments on variable note receivable		—			(5,428,542	)		(815,937	)		(7,424,727	)
Fair value adjustments on warrants issued		(3,181,114	)		—			(2,060,771	)		—
Fair value adjustments on contingent consideration		442,991			—			425,426			—
Other		1,036,793			39,678			1,835,670			388,277


Total Other Income (Expense)	$	6,432,883		$	(6,585,540	)	$	7,501,566		$	(7,969,433	)

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2020

Disclosure Text Block Supplement [Abstract]

Fair Value Measurements, Recurring and Nonrecurring


	As of September 30, 2020
	Level 1		Level 2		Level 3			Total

Cash and Cash Equivalents	$	78,091,073	$	—	$	—		$	78,091,073
Investments		675,594		—		21,535,406			22,210,999
Liability of Redemption of Noncontrolling Interest		—		—		—			—
Contingent Consideration Payable		—		—		(36,315,360	)		(36,315,360	)
Warrant Liability		—		—		(18,513,000	)		(18,513,000	)

	$	78,766,667	$	—	$	(33,292,954	)	$	45,473,712



	As of December 31, 2019
	Level 1		Level 2		Level 3			Total

Cash and Cash Equivalents	$	46,667,334	$	—	$	—		$	46,667,334
Notes Receivable		—		—		815,937			815,937
Investments		—		—		14,068,821			14,068,821
Liability of Redemption of Noncontrolling Interest		—		—		(5,500,000	)		(5,500,000	)
Contingent Consideration Payable		—		—		(58,936,739	)		(58,936,739	)
Warrant Liability		—		—		(15,879,843	)		(15,879,843	)

	$	46,667,334	$	—	$	(65,431,824	)	$	(18,764,490	)

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References + Details

Variable Interest Entities (Tables)

9 Months Ended

Sep. 30, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Variable Interest Entities


	September 30, 2020						December 31, 2019
	Chesapeake Alternatives, LLC		Illinois Disp, LLC		Other Non-material VIEs		Chesapeake Alternatives, LLC		Illinois Disp, LLC		Other Non-material VIEs
Current assets	$	29,728,652	$	2,489,118	$	2,261,685	$	19,455,533	$	1,381,716	$	1,352,935
Non-current assets		3,041,401		3,752,645		2,353,991		22,384,663		3,083,659		2,534,297
Current liabilities		21,228,691		898,661		1,108,292		14,219,204		149,498		783,682
Non-current liabilities		785,724		473,136		802,823		1,169,989		137,736		855,440
Equity attributable to noncontrolling interests		298,252		2,309,983		85,561		350,206		2,089,071		(22,488	)
Equity attributable to Green Thumb Industries Inc.		10,457,386		2,309,983		2,619,001		6,645,263		2,089,070		2,270,598


	Three Months Ended
	September 30, 2020						September 30, 2019
	Chesapeake Alternatives, LLC		Illinois Disp, LLC		Other Non-material VIEs		Chesapeake Alternatives, LLC			Illinois Disp, LLC		Other Non-material VIEs
Revenues	$	5,684,349	$	5,224,583	$	2,695,781	$	4,369,436		$	1,620,065	$	689,097
Net income (loss) attributable to noncontrolling interests		26,134		897,494		185,452		1,807,394			185,930		(1,624,850	)
Net income (loss) attributable to Green Thumb Industries Inc.		1,033,650		897,494		294,969		(971,880	)		185,931		1,059,653


Net income (loss)	$	1,059,784	$	1,794,988	$	480,421	$	835,514		$	371,860	$	(565,197	)


	Nine Months Ended
	September 30, 2020						September 30, 2019
	Chesapeake Alternatives, LLC		Illinois Disp, LLC		Other Non-material VIEs		Chesapeake Alternatives, LLC		Illinois Disp, LLC		Other Non-material VIEs
Revenues	$	14,792,710	$	13,170,514	$	6,778,501	$	12,458,427	$	4,174,045	$	2,373,042
Net income (loss) attributable to noncontrolling interests		206,929		2,170,912		319,511		2,244,546		506,972		(2,307,097	)
Net income (loss) attributable to Green Thumb Industries Inc.		3,812,121		2,170,913		661,341		—		506,972		—


Net income (loss)	$	4,019,050	$	4,341,825	$	980,852	$	2,244,546	$	1,013,943	$	(2,307,097	)

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details

Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Schedule of Revenues

The below table presents revenues by type for the three and nine months ended September 30, 2020 and 2019:


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020			2019			2020			2019
Revenues, Net of Discounts
Consumer Packaged Goods	$	74,702,069		$	35,093,858		$	177,355,614		$	71,651,968
Retail		111,948,115			43,532,286			275,451,137			85,501,646
Intersegment Eliminations		(29,546,343	)		(10,635,237	)		(73,460,384	)		(16,522,767	)

Total Revenues, net of discounts	$	157,103,841		$	67,990,907		$	379,346,367		$	140,630,847

Depreciation and Amortization
Consumer Packaged Goods	$	10,029,857		$	7,226,614		$	33,089,808		$	16,100,635
Retail		1,505,019			687,199			5,309,152			1,428,256
Intersegment Eliminations		—			—			—			—

Total Depreciation and Amortization	$	11,534,876		$	7,913,813		$	38,479,960		$	17,528,891

Income Taxes
Consumer Packaged Goods	$	12,928,449		$	1,072,333		$	23,553,449		$	1,761,333
Retail		15,507.883			5,128,000			33,410,598			9,028,000
Intersegment Eliminations and Corporate		—			(2,576,000	)		—			(6,083,333	)

Total Income Taxes	$	28,436,332		$	3,624,333		$	56,964,047		$	4,706,000

Overview and Basis of Presentation - Additional Information (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Number of Shares Outstanding, Diluted	214,212,292	204,709,085	210,127,323	184,851,805
Stock Options Expense
Number of Shares Outstanding, Diluted			5,782,599	6,031,833
Weighted Average Number Diluted Shares Outstanding Adjustment	1,928,946
Restricted Stock Units
Number of Shares Outstanding, Diluted			688,507	1,479,038
Weighted Average Number Diluted Shares Outstanding Adjustment	151,458
Warrant
Number of Shares Outstanding, Diluted			2,520,794	2,041,735
Weighted Average Number Diluted Shares Outstanding Adjustment	141,482

Inventories - Summary of inventory (Detail) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Inventory [Line Items]
Raw Material	$ 3,603,977	$ 6,375,032
Packaging and Miscellaneous	6,173,017	4,887,970
Work in Process	24,945,006	20,162,723
Finished Goods	22,430,016	16,640,629
Reserve for Obsolete Inventory	(1,987,758)	(2,031,873)
Total Inventories	$ 55,164,258	$ 46,034,481

Property and Equipment - Property, Plant and Equipment (Detail) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Cost
Beginning balance	$ 164,713,394	$ 69,207,422
Additions	45,385,505	100,900,501
Additions from acquisitions		16,525,362
Disposals	(12,465,405)	(21,919,891)
Ending balance	197,633,494	164,713,394
Accumulated Depreciation
Beginning balance	9,116,719	3,883,342
Ending balance	19,908,402	9,116,719
Net book value [Abstract]
Beginning balance	155,596,675	65,324,080
Ending balance	177,725,092	155,596,675
Land [member]
Cost
Beginning balance	3,272,439	2,243,085
Additions	586.867	4,393,030
Disposals	(979,930)	(3,363,676)
Ending balance	2,879,376	3,272,439
Accumulated Depreciation
Beginning balance	0
Ending balance	0	0
Net book value [Abstract]
Beginning balance	3,272,439	2,243,085
Ending balance	2,879,376	3,272,439
Buildings and Improvements [member]
Cost
Beginning balance	33,377,471	20,861,988
Additions	21,128,482	28,217,500
Disposals	(4,507,086)	(15,702,017)
Ending balance	49,998,867	33,377,471
Accumulated Depreciation
Beginning balance	2,236,254	1,351,230
Ending balance	2,939,951	2,236,254
Net book value [Abstract]
Beginning balance	31,141,217	19,510,758
Ending balance	47,058,916	31,141,217
Equipment Computers And Furniture [Member]
Cost
Beginning balance	35,509,871	11,001,498
Additions	4,794,342	23,109,209
Additions from acquisitions		4,253,362
Disposals	0	(2,854,198)
Ending balance	40,304,213	35,509,871
Accumulated Depreciation
Beginning balance	3,882,178	1,524,114
Ending balance	8,375,318	3,882,178
Net book value [Abstract]
Beginning balance	31,627,693	9,477,384
Ending balance	31,928,895	31,627,693
Leasehold Improvements [member]
Cost
Beginning balance	68,681,497	18,435,893
Additions	12,413,970	38,002,678
Additions from acquisitions		12,242,926
Disposals	0
Ending balance	81,095,467	68,681,497
Accumulated Depreciation
Beginning balance	2,998,287	1,007,998
Ending balance	8,426,333	2,998,287
Net book value [Abstract]
Beginning balance	65,683,210	17,427,895
Ending balance	72,669,134	65,683,210
Assets Under Construction [member]
Cost
Beginning balance	21,372,116	16,664,958
Additions	6,118,878	4,678,084
Additions from acquisitions		29,074
Disposals	(6,978,389)	0
Ending balance	20,512,605	21,372,116
Accumulated Depreciation
Beginning balance	0
Ending balance	0	0
Net book value [Abstract]
Beginning balance	21,372,116	16,664,958
Ending balance	20,512,605	21,372,116
Capitalized Interest [Member]
Cost
Beginning balance	2,500,000
Additions	342,966	2,500,000
Disposals	0
Ending balance	2,842,966	2,500,000
Accumulated Depreciation
Beginning balance	0
Ending balance	166,800	0
Net book value [Abstract]
Beginning balance	2,500,000
Ending balance	$ 2,676,166	$ 2,500,000

Property and Equipment - Additional Information (Detail) - USD ($)		3 Months Ended		9 Months Ended
	Mar. 06, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Jan. 31, 2020
Disclosure of Property of Equipment [Line Items]
Depreciation expense		$ 2,003,585	$ 2,494,601	$ 11,193,570	$ 5,113,195
Ohio Cultivation And Processing Facility [member]
Disclosure of Property of Equipment [Line Items]
Sale Leaseback Transaction, Net Book Value						$ 2,900,000
Ohio Cultivation And Processing Facility [member] \| Innovative Industrial Properties [member] \| Land [Member]
Disclosure of Property of Equipment [Line Items]
Sale Leaseback Transaction, Net Book Value						205,000
Ohio Cultivation And Processing Facility [member] \| Innovative Industrial Properties [member] \| Asset under Construction [Member]
Disclosure of Property of Equipment [Line Items]
Sale Leaseback Transaction, Net Book Value						$ 2,695,000
Illinois Cultivation And Processing Facility [member]
Disclosure of Property of Equipment [Line Items]
Sale Leaseback Transaction, Net Book Value	$ 9,000,000
Illinois Cultivation And Processing Facility [member] \| Innovative Industrial Properties [member] \| Land [Member]
Disclosure of Property of Equipment [Line Items]
Sale Leaseback Transaction, Net Book Value	774,930
Illinois Cultivation And Processing Facility [member] \| Innovative Industrial Properties [member] \| Asset under Construction [Member]
Disclosure of Property of Equipment [Line Items]
Sale Leaseback Transaction, Net Book Value	3,813,636
Illinois Cultivation And Processing Facility [member] \| Innovative Industrial Properties [member] \| Other Operating Income (Expense) [Member]
Disclosure of Property of Equipment [Line Items]
Sale and Leaseback Transaction, Gain, Net	239,096
Illinois Cultivation And Processing Facility [member] \| Innovative Industrial Properties [member] \| Building and Building Improvements [Member]
Disclosure of Property of Equipment [Line Items]
Sale Leaseback Transaction, Net Book Value	$ 4,507,086
Cost of Sales [member]
Disclosure of Property of Equipment [Line Items]
Depreciation expense		$ 311,315	$ 1,732,146	$ 5,571,477	$ 3,541,236

Intangible Assets And Goodwill - Summary Of Intangible Assets (Detail) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Jan. 01, 2020	Jan. 01, 2019
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross			$ 462,253,283	$ 90,905,693	$ 90,905,693
Adjustments to Purchase Price Allocation			1,695,009
Additions from acquisitions					371,347,590
Finite-Lived Intangible Assets, Gross	$ 463,948,292		463,948,292		462,253,283
Finite-Lived Intangible Assets, Accumulated Amortization			27,006,385	2,540,015	2,540,015
Amortization	9,531,290	$ 5,419,212	27,286,390	12,415,696	24,466,370
Finite-Lived Intangible Assets, Accumulated Amortization	54,292,775		54,292,775		27,006,385
Finite-Lived Intangible Assets, Net	409,655,517		409,655,517		435,246,898	$ 435,246,898	$ 88,365,678
Licenses And Permits [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross			336,954,213	89,705,213	89,705,213
Adjustments to Purchase Price Allocation			(145,000)
Additions from acquisitions					247,249,000
Finite-Lived Intangible Assets, Gross	336,809,213		336,809,213		336,954,213
Finite-Lived Intangible Assets, Accumulated Amortization			18,477,500	2,322,715	2,322,715
Amortization			17,701,556		16,154,785
Finite-Lived Intangible Assets, Accumulated Amortization	36,179,056		36,179,056		18,477,500
Finite-Lived Intangible Assets, Net	300,630,157		300,630,157		318,476,713	318,476,713	87,382,498
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross			97,455,590	360,000	360,000
Adjustments to Purchase Price Allocation			1,840,009
Additions from acquisitions					97,095,590
Finite-Lived Intangible Assets, Gross	99,295,599		99,295,599		97,455,590
Finite-Lived Intangible Assets, Accumulated Amortization			4,121,800	0	0
Amortization			6,412,282		4,121,800
Finite-Lived Intangible Assets, Accumulated Amortization	10,534,082		10,534,082		4,121,800
Finite-Lived Intangible Assets, Net	88,761,517		88,761,517		93,333,790	93,333,790	360,000
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross			25,258,000	820,000	820,000
Additions from acquisitions					24,438,000
Finite-Lived Intangible Assets, Gross	25,258,000		25,258,000		25,258,000
Finite-Lived Intangible Assets, Accumulated Amortization			3,932,416	204,500	204,500
Amortization			2,777,802		3,727,916
Finite-Lived Intangible Assets, Accumulated Amortization	6,710,218		6,710,218		3,932,416
Finite-Lived Intangible Assets, Net	18,547,782		18,547,782		21,325,584	21,325,584	615,500
Non Competition Agreement [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross			2,585,480	20,480	20,480
Additions from acquisitions					2,565,000
Finite-Lived Intangible Assets, Gross	2,585,480		2,585,480		2,585,480
Finite-Lived Intangible Assets, Accumulated Amortization			474,669	$ 12,800	12,800
Amortization			394,750		461,869
Finite-Lived Intangible Assets, Accumulated Amortization	869,419		869,419		474,669
Finite-Lived Intangible Assets, Net	$ 1,716,061		$ 1,716,061		$ 2,110,811	$ 2,110,811	$ 7,680

Intangible Assets And Goodwill - Additional Information (Detail) - USD ($)			3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 01, 2020	Jun. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Amortization			$ 9,531,290	$ 5,419,212	$ 27,286,390	$ 12,415,696	$ 24,466,370
Measurement period adjustment in intangible assets			1,840,009
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year			9,693,141		9,693,141
Adjustments to Purchase Price Allocations					(2,003,275)		4,672,523
RetailSegment [Member] \| Fiorello Pharmaceuticals Inc [Member]
Adjustments to Purchase Price Allocations					1,000,000
Consumer Packaged Goods Segments [Member] \| For Success Holdings Companys [Member]
Adjustments to Purchase Price Allocations					1,687,700
Consumer Packaged Goods Segments [Member] \| Advanced Grow Labs LLC [Member]
Adjustments to Purchase Price Allocations					1,507,000
Trade Names [Member]
Amortization					6,412,282		$ 4,121,800
Trade Names [Member] \| RetailSegment [Member]
Acquired Finite-Lived Intangible Asset, Useful Life	7 years	15 years
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year			1,266,880		1,266,880
Finite-Lived Intangible Asset, Amortization Expense From Year Two To Five			5,067,520		5,067,520
Finite Lived Intangible Assets, Reduction In amortization expense			$ 21,536,960		$ 21,536,960

Intangible Assets And Goodwill - Summary Of Estimated Annual Amortization Expense Related To Intangible Assets (Detail) - USD ($)	Sep. 30, 2020	Jan. 01, 2020	Dec. 31, 2019	Jan. 01, 2019
Finite Lived Intangible Assets Future Amortization Expense [Line Items]
Remainder of 2020	$ 9,693,141
2021	38,772,564
2022	38,341,825
2023	38,259,009
2024	37,677,676
Thereafter	246,911,302
Finite-Lived Intangible Assets, Net	409,655,517	$ 435,246,898	$ 435,246,898	$ 88,365,678
Previously Reported [Member]
Finite Lived Intangible Assets Future Amortization Expense [Line Items]
Remainder of 2020	8,426,261
2021	33,705,044
2022	33,274,305
2023	33,191,489
2024	32,610,156
Thereafter	268,448,262
Finite-Lived Intangible Assets, Net	409,655,517
Intangible Assets, Amortization Period [Member] \| Restatement Adjustment [Member]
Finite Lived Intangible Assets Future Amortization Expense [Line Items]
Remainder of 2020	1,266,880
2021	5,067,520
2022	5,067,520
2023	5,067,520
2024	5,067,520
Thereafter	$ (21,536,960)

Intangible Assets And Goodwill - Summary Of Goodwill And Intangible Assets Disclosure (Detail) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Goodwill [Line Items]
Balance at beginning	$ 375,084,991	$ 39,204,360
Adjustments to Purchase Price Allocations	(2,003,275)	4,672,523
Balance at end	373,081,716	375,084,991
Advanced Grow Labs LLC [Member]
Goodwill [Line Items]
Acquisitions		61,328,599
Integral Associates LLC [Member]
Goodwill [Line Items]
Acquisitions		115,979,323
Other Acquisitions [Member]
Goodwill [Line Items]
Acquisitions		153,900,188
Retail Segment [Member]
Goodwill [Line Items]
Balance at beginning	119,873,759	15,286,360
Adjustments to Purchase Price Allocations	1,191,425	8,238,808
Balance at end	121,065,184	119,873,759
Retail Segment [Member] \| Advanced Grow Labs LLC [Member]
Goodwill [Line Items]
Acquisitions		16,756,250
Retail Segment [Member] \| Integral Associates LLC [Member]
Goodwill [Line Items]
Acquisitions		46,655,753
Retail Segment [Member] \| Other Acquisitions [Member]
Goodwill [Line Items]
Acquisitions		32,936,590
Consumer Packaged Goods Segment [Member]
Goodwill [Line Items]
Balance at beginning	255,211,232	23,918,000
Adjustments to Purchase Price Allocations	(3,194,700)	(3,566,285)
Balance at end	$ 252,016,532	255,211,232
Consumer Packaged Goods Segment [Member] \| Advanced Grow Labs LLC [Member]
Goodwill [Line Items]
Acquisitions		44,572,349
Consumer Packaged Goods Segment [Member] \| Integral Associates LLC [Member]
Goodwill [Line Items]
Acquisitions		69,323,570
Consumer Packaged Goods Segment [Member] \| Other Acquisitions [Member]
Goodwill [Line Items]
Acquisitions		$ 120,963,598

Leases - Additional Information (Detail) - USD ($)		3 Months Ended		9 Months Ended
Leases - Additional Information (Detail) - USD ($)	Jun. 05, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Oct. 01, 2020	Mar. 06, 2020	Jan. 31, 2020	Dec. 31, 2019
Acquired Finite-Lived Intangible Assets [Line Items]
Operating lease expense		$ 6,590,553	$ 1,962,561	$ 19,021,190	$ 4,229,889
Operating lease right of use asset		99,447,497		99,447,497					$ 63,647,812
Operating lease liability		107,062,494		107,062,494
Payments to acquire property plant and equipment				49,221,442	66,875,245
Ohio Cultivation And Processing Facility [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Sale Leaseback Transaction, Net Book Value								$ 2,900,000
Sale leaseback certain improvements agreed to provide reimbursement								$ 4,300,000
Ohio Cultivation And Processing Facility [Member] \| Subsequent Event [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Sale Leaseback Transaction, Net Book Value						$ 32,200,000
Sale leaseback investment additional amount						$ 25,000,000
Illinois Cultivation And Processing Facility [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Lease term							16 years
Sale Leaseback Transaction, Net Book Value							$ 9,000,000
Sale leaseback certain improvements agreed to provide reimbursement							41,000,000
Sale leaseback investment amount							50,000,000
Operating lease right of use asset							26,828,221
Operating lease liability							26,828,221
Improvements allowance							$ 41,000,000
Mosaic Real Estate Joliet LLC [Member] \| Building and Building Improvements [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Payments to acquire property plant and equipment	$ 1,814,000
Florida And Lllinois [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Operating lease expense		157,076	$ 148,226	601,753	$ 339,961
NV
Acquired Finite-Lived Intangible Assets [Line Items]
Operating lease expense		$ 58,332		$ 77,776
Maximum [Member] \| Florida And Lllinois [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Lease term		15 years		15 years
Maximum [Member] \| Maryland Nevada and Massachusetts [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Lease term		15 years		15 years
Minimum [Member] \| Florida And Lllinois [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Lease term		7 years		7 years
Minimum [Member] \| Maryland Nevada and Massachusetts [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Lease term		7 years		7 years

Leases - Schedule Of Other Information Related To Operating Leases (Detail)	Sep. 30, 2020
Lessee, Lease, Description [Line Items]
Weighted average remaining lease term	10 years 9 months 21 days
Weighted average discount rate	13.20%

Leases - Lessee Operating Lease Liability Maturity (Detail)	Sep. 30, 2020 USD ($)
Lessee, Lease, Description [Line Items]
Remainder of 2020	$ 5,090,244
2021	23,550,845
2022	23,622,966
2023	23,460,653
2024	22,643,008
2025 and Thereafter	194,344,019
Total Lease Payments	292,711,735
Less: Interest	(185,649,241)
Present Value of Lease Liability	107,062,494
Third Party [Member]
Lessee, Lease, Description [Line Items]
Remainder of 2020	4,767,957
2021	22,243,662
2022	22,285,836
2023	22,092,882
2024	21,387,294
2025 and Thereafter	183,998,689
Total Lease Payments	276,776,320
Less: Interest	(177,811,636)
Present Value of Lease Liability	98,964,684
Related Party [Member]
Lessee, Lease, Description [Line Items]
Remainder of 2020	322,287
2021	1,307,183
2022	1,337,130
2023	1,367,771
2024	1,255,714
2025 and Thereafter	10,345,330
Total Lease Payments	15,935,415
Less: Interest	(7,837,605)
Present Value of Lease Liability	$ 8,907,810

Notes Payable - Schedule of Debt (Detail) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Total notes payable	$ 97,059,260	$ 91,346,869
Less: current portion of notes payable	(301,027)	(206,675)
Notes payable, net of current portion	96,758,233	91,140,194
Acquired Debt [member]
Debt Instrument [Line Items]
Total notes payable	763,284	970,957
Private Placement Debt [member]
Debt Instrument [Line Items]
Total notes payable	93,848,029	90,375,912
Rise Joliet mortgage [Member]
Debt Instrument [Line Items]
Total notes payable	1,616,606	0
Rise Lakewood mortgage [Member]
Debt Instrument [Line Items]
Total notes payable	$ 831,341	$ 0

Notes Payable - Schedule of Debt (Parenthetical) (Detail) - USD ($)				12 Months Ended
	Aug. 20, 2020	Jun. 05, 2020	May 22, 2019	Dec. 31, 2017	Sep. 30, 2020
Debt Instrument [Line Items]
Charitable Contribution Quarterly Payment				$ 50,000
Charitable Contribution, Date Of Last Payment				October 2024
Debt Instrument Interest Rate	7.25%	5.00%		2.17%
Debt Maturity Date	Aug. 20, 2025	Jun. 05, 2035
Private Placement Debt [member]
Debt Instrument [Line Items]
Debt Instrument Interest Rate					12.00%
Debt Issuance Date			May 22, 2019
Debt face value			$ 105,466,429
Debt Maturity Date			May 22, 2023
Debt Instrument Carrying Amount					$ 11,618,400
Rise Joliet mortgage [Member]
Debt Instrument [Line Items]
Debt Instrument Interest Rate					5.00%
Debt Issuance Date		Jun. 05, 2020
Debt face value		$ 1,814,000
Debt Maturity Date		Jun. 05, 2035
Debt Instrument Carrying Amount					$ 177,244
Rise Lakewood mortgage [Member]
Debt Instrument [Line Items]
Debt Instrument Interest Rate	7.25%
Debt face value	$ 833,000
Debt Maturity Date	Aug. 20, 2025

Notes Payable - Additional Information (Detail) - USD ($)			9 Months Ended
	Aug. 20, 2020	Jun. 05, 2020	Sep. 30, 2020	Dec. 31, 2017
Mortgage Loans	$ 833,000	$ 1,814,000
Mortage loan interest rate	7.25%	5.00%		2.17%
Maturity date	Aug. 20, 2025	Jun. 05, 2035
Debt held by related parties			1.00%
Debt held by unrelated third-parties			99.00%
Warrant
Warrants issued		35,000
Warrants issued, Value		$ 181,272

Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Detail) - 9 months ended Sep. 30, 2020	$ / shares shares	$ / shares shares
Class of Warrant or Right [Line Items]
Number of Shares, Ending Balance	2,485,794	2,485,794
Liability Classified Warrant [member]
Class of Warrant or Right [Line Items]
Number of Shares, Beginning Balance	2,406,811	2,406,811
Number of Shares, Ending Balance	2,485,794	2,485,794
Weighted Average Exercise Price, Beginning Balance \| $ / shares	$ 18.59
Weighted Average Exercise Price, Ending Balance \| $ / shares	$ 18.45
Weighted Average Contractual Life, Beginning Balance	4 years 10 months 9 days	4 years 10 months 9 days
Weighted Average Contractual Life, Ending Balance	4 years 10 months 13 days	4 years 10 months 13 days
Equity Classified Warrant [member]
Class of Warrant or Right [Line Items]
Number of Shares, Ending Balance	35,000	35,000
Weighted Average Exercise Price, Ending Balance \| $ / shares		$ 9.10
Weighted Average Contractual Life, Ending Balance	5 years	5 years
Additional Modifications Warrants [member] \| Liability Classified Warrant [member]
Class of Warrant or Right [Line Items]
Number of Shares, Granted	84,924	84,924
Weighted Average Exercise Price, Granted \| $ / shares	$ 14.03
Weighted Average Contractual Life, Granted	5 years	5 years
Dispensary Mortgage Warrants [member] \| Equity Classified Warrant [member]
Class of Warrant or Right [Line Items]
Number of Shares, Granted	35,000	35,000
Number of Shares, Ending Balance	35,000	35,000
Weighted Average Exercise Price, Granted \| $ / shares		$ 9.10
Weighted Average Contractual Life, Granted	5 years	5 years
Warrants Exercised [Member] \| Liability Classified Warrant [member]
Class of Warrant or Right [Line Items]
Number of Shares, Granted	5,941	5,941
Weighted Average Exercise Price, Granted \| $ / shares	$ 12.42
Weighted Average Contractual Life, Granted	5 years	5 years

Warrants - Summary of the Significant Assumptions Used in Determining the Fair Value of the Additional Modification Warrants (Detail)	Sep. 30, 2020 yr	May 21, 2020 yr
Equity Volatility
Class of Warrant or Right [Line Items]
Warrants and Rights Outstanding, Measurement Input	0
Equity Volatility \| Additional Modifications Warrants [member]
Class of Warrant or Right [Line Items]
Warrants and Rights Outstanding, Measurement Input		100
Remaining Term
Class of Warrant or Right [Line Items]
Warrants and Rights Outstanding, Measurement Input	0
Remaining Term \| Additional Modifications Warrants [member]
Class of Warrant or Right [Line Items]
Warrants and Rights Outstanding, Measurement Input		5
Risk free rate
Class of Warrant or Right [Line Items]
Warrants and Rights Outstanding, Measurement Input	0
Risk free rate \| Additional Modifications Warrants [member]
Class of Warrant or Right [Line Items]
Warrants and Rights Outstanding, Measurement Input		0.42

Warrants - Additional Information (Detail) - USD ($)			3 Months Ended	9 Months Ended
Warrants - Additional Information (Detail) - USD ($)	Jun. 05, 2020	May 22, 2020	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	May 21, 2020	Dec. 31, 2019
Class of Warrant or Right [Line Items]
Fair Value Adjustment of Warrants			$ (3,181,114)	$ (2,060,771)
Warrants Issued	35,000					84,924
Warrant Liability			18,513,000	18,513,000			$ 15,879,843
Proceeds from issuance of notes payable					$ 117,435,724
Rise Joliet mortgage [member]
Class of Warrant or Right [Line Items]
Proceeds from issuance of notes payable	$ 1,814,000
Additional Modification Warrants [member]
Class of Warrant or Right [Line Items]
Number of Shares, Granted		84,924
Warrant Liability			739,500	739,500
Additional Modification Warrants [member] \| Liability Classified Warrant [member]
Class of Warrant or Right [Line Items]
Warrant Liability			572,387	572,387
Additional Modification Warrants [member] \| Equity Classified Warrant [member]
Class of Warrant or Right [Line Items]
Warrant Liability			$ 181,272	$ 181,272

Warrants - Schedule Of Fair Value Of Warrant Liability (Detail)	Sep. 30, 2020 USD ($) shares	Sep. 30, 2020 $ / shares	Dec. 31, 2019 USD ($)
Class of Warrant or Right [Line Items]
Warrants Outstanding \| shares	2,485,794
Warrant Liability \| $	$ 18,513,000		$ 15,879,843
Bridge Financing Warrants [member]
Class of Warrant or Right [Line Items]
Strike Price \| $ / shares		$ 22.90
Warrants Outstanding \| shares	218,964
Warrant Liability \| $	$ 1,065,000		1,385,400
Private Placement Financing Warrants [member]
Class of Warrant or Right [Line Items]
Strike Price \| $ / shares		19.39
Warrants Outstanding \| shares	1,822,771
Warrant Liability \| $	$ 13,457,000		12,189,169
Modification Warrants [member]
Class of Warrant or Right [Line Items]
Strike Price \| $ / shares		12.04
Warrants Outstanding \| shares	360,256
Warrant Liability \| $	$ 3,251,500		$ 2,305,274
Additional Modification Warrants [member]
Class of Warrant or Right [Line Items]
Strike Price \| $ / shares		$ 14.03
Warrants Outstanding \| shares	83,803
Warrant Liability \| $	$ 739,500

Warrants - Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability (Detail)	Sep. 30, 2020 yr	Dec. 31, 2019 yr
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0
Volatility \| Maximum [Member] \| Liability Classified Warrant [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	89.50	123.64
Volatility \| Minimum [Member] \| Liability Classified Warrant [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	85.36	117.43
Remaining Term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0
Remaining Term \| Maximum [Member] \| Liability Classified Warrant [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	4.64	4.86
Remaining Term \| Minimum [Member] \| Liability Classified Warrant [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	2.03	2.78
Risk Free Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0
Risk Free Rate \| Maximum [Member] \| Liability Classified Warrant [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.34	1.69
Risk Free Rate \| Minimum [Member] \| Liability Classified Warrant [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.25	1.68

Warrants - Fair Value Of The Equity Classified Warrants (Detail) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Class of Warrant or Right [Line Items]
Warrants Outstanding	2,485,794
Warrant Liability	$ 18,513,000	$ 15,879,843
Equity Classified Warrant [member]
Class of Warrant or Right [Line Items]
Warrants Outstanding	35,000
Dispensary Mortgage Warrants [member] \| Equity Classified Warrant [member]
Class of Warrant or Right [Line Items]
Strike Price	$ 9.10
Warrants Outstanding	35,000
Warrant Liability	$ 181,272

Warrants - Summarizes The Significant Assumptions Used In Determining The Fair Value Of The Equity Classified Warrants (Detail)	Sep. 30, 2020 yr
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0
Volatility \| Equity Classified Warrant [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.80
Remaining Term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0
Remaining Term \| Equity Classified Warrant [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	5
Risk Free Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0
Risk Free Rate \| Equity Classified Warrant [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	37

Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Tax Expense (Benefit), Continuing Operations [Abstract]
Income/(Loss) before Income Taxes	$ 39,189,341	$ (10,713,603)	$ 52,189,559	$ (40,011,094)
Income Tax Expense	$ 28,436,332	$ 3,624,333	$ 56,964,047	$ 4,706,000
Effective Tax Rate	72.60%	(33.80%)	109.10%	(11.80%)

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

Income Taxes - Additional Information (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Income Tax Disclosure [Abstract]
unrecognized tax benefits	$ 16,264,727		$ 2,113,263
Income tax paid	$ 37,820,228	$ 10,534,408

Investments - Schedule Of Long Term Investments (Detail) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Longterm Investments [Line Items]
Beginning balance			$ 14,068,821	$ 40,933,283	$ 40,933,283
Additions			25,000
Fair value adjustment	$ 8,134,213	$ (1,196,676)	8,117,178	(932,983)	(5,459,462)
Applied to consideration in business combination					(21,405,000)
Ending balance	22,210,999		22,210,999		14,068,821
Convertible Debt Securities [member]
Longterm Investments [Line Items]
Beginning balance			7,533,000	30,336,000	30,336,000
Conversion of notes receivable			(7,533,000)
Fair value adjustment					(1,398,000)
Applied to consideration in business combination					(21,405,000)
Ending balance					7,533,000
Equity Securities [member]
Longterm Investments [Line Items]
Beginning balance			6,535,821	$ 10,597,283	10,597,283
Additions			25,000
Conversion of notes receivable			7,533,000
Fair value adjustment			8,117,178		(4,061,462)
Ending balance	$ 22,210,999		$ 22,210,999		$ 6,535,821

Investments - Summary Of Equity Investments were Valued Using a Market Approach (Detail)	Sep. 30, 2020
Measurement Input Discount For Lack Of Control [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity Securities, Measurement Input	13
Measurement Input, Discount for Lack of Marketability [Member] \| Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity Securities, Measurement Input	30
Measurement Input, Discount for Lack of Marketability [Member] \| Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity Securities, Measurement Input	10

Investments - Schedule Of Fair Value Measurement Inputs and Valuation Techniques (Detail)	Dec. 31, 2019
Risk free rate \| Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	2.46
Risk free rate \| Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	1.58
Equity Volatility \| Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	106
Equity Volatility \| Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	58
Market Yield \| Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	18
Market Yield \| Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	15
Probability of Qualified Financing
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	0
Probability of Sale
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	30
Probability of No Event
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	70

Share Capital - Schedule of Common Stock Outstanding Roll Forward (Detail) - USD ($)			3 Months Ended	9 Months Ended
	May 15, 2020	Dec. 31, 2019	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019
Class of Stock [Line Items]
Distribution of contingent consideration				2,713,463
Distribution of deferred shares	101,695	1,367,643
Issuance of shares for redemption of noncontrolling interests			$ 5,350,000	$ 5,350,000	$ 25,068,847
Issuance of shares upon exercise of options and warrants			$ 448,424	$ 656,096
Subordinate Voting Shares [member]
Class of Stock [Line Items]
Beginning balance				128,999,964
Issuance of shares under business combinations and investments				238,450
Distribution of contingent consideration				2,713,463
Distribution of deferred shares				1,220,548
Issuance of shares for redemption of noncontrolling interests				$ 1,315,789
Issuance of shares upon exercise of options and warrants				$ 71,384
Issuances of shares upon vesting of RSUs				901,023
Exchange of shares				27,539,300
Ending balance		128,999,964	162,999,921	162,999,921
Multiple Voting Shares [member]
Class of Stock [Line Items]
Beginning balance				373,350
Exchange of shares				(252,440)
Ending balance		373,350	120,910	120,910
Super Voting Shares [member]
Class of Stock [Line Items]
Beginning balance				402,289
Exchange of shares				(22,953)
Ending balance		402,289	379,336	379,336

Share Capital - Share-based Payment Arrangement, Option, Activity (Detail) - 9 months ended Sep. 30, 2020	USD ($) yr shares	$ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Balance \| shares	3,839,017
Number of Share, Granted \| shares	2,496,511
Number of Shares, Exercised \| shares	(65,443)
Number of Shares, Forfeited \| shares	(487,486)
Number of Share, Vested \| shares	1,635,030
Number of Shares, Ending Balance \| shares	5,782,599
Number of Share, Exercisable \| shares		1,516,872
Weighted Average Exercise Price, Balance \| $ / shares		$ 13.21
Weighted Average Exercise Price, Granted \| $ / shares		9.76
Weighted Average Exercise Price, Exercised \| $ / shares		11.02
Weighted Average Exercise Price, Forfeited \| $ / shares		13.82
Weighted Average Exercise Price, Vested \| $ / shares		13.36
Weighted Average Exercise Price, Ending Balance \| $ / shares		11.69
Weighted Average Exercise Price, Exercisable \| $ / shares		$ 13.22
Weighted Average Contractual Life, Balance \| yr	5.81
Weighted Average Contractual Life Granted	5 years
Weighted Average Contractual Life Exercised	3 years 11 months 23 days
Weighted Average Contractual Life Forfeited	5 years 2 months 19 days
Weighted Average Contractual Life, Vested	6 years 7 months 24 days
Weighted Average Contractual Life, Ending Balance \| yr	5.53
Weighted Average Contractual Life, Exercisable	6 years 8 months 23 days
Aggregate Intrinsic Value, Balance \| $	$ 218,234
Aggregate Intrinsic Value, Exercised \| $	$ 4,601,129

Share Capital - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail)	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Risk-free interest rate, Minumum	0.36%
Risk-free interest rate, Maximum	2.33%
Expected dividend yield	0.00%
Expected volatility, Minumum	80.00%
Expected volatility, maximum	100.00%
Minimum [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Expected option life	3 years
Maximum [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Expected option life	10 years

Share Capital - Non-vested Restricted Stock Shares Activity (Detail) - Restricted Stock Units (RSUs) [Member]	9 Months Ended
	Sep. 30, 2020 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Balance \| shares	1,399,762
Number of Shares, Granted \| shares	254,268
Number of Shares, Forfeited \| shares	(64,500)
Number of Shares, Vested \| shares	(901,023)
Number of Shares, Balance \| shares	688,507
Weighted Average Grant Date Fair Value, Balance \| $ / shares	$ 9.30
Weighted Average Grant Date Fair Value, Granted \| $ / shares	1,265
Weighted Average Grant Date Fair Value, Forfeited \| $ / shares	15.60
Weighted Average Grant Date Fair Value, Vested \| $ / shares	14.85
Weighted Average Grant Date Fair Value, Balance \| $ / shares	$ 16.77

Share Capital - Schedule of Stock-Based Compensation Expense (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-Based Compensation Expense	$ 4,435,634	$ 3,564,095	$ 15,209,520	$ 13,324,083
Stock options expense
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-Based Compensation Expense	2,614,273	1,666,465	8,209,557	4,248,461
Restricted Stock Units
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-Based Compensation Expense	$ 1,821,054	$ 1,897,630	$ 6,999,963	$ 9,075,622

Share Capital - Schedule of Business Acquisitions of Contingent Consideration (Detail)	9 Months Ended
	Sep. 30, 2020 USD ($) shares
Issuance of shares under business combinations and investments \| shares	2,713,463
Stock Issued During Period, Value, Acquisitions \| $	$ 22,885,813
Advanced Grow Labs, LLC [Member]
Business Acquisition, Date of Transaction	Feb. 12, 2019
Issuance of shares under business combinations and investments \| shares	1,396,533
Stock Issued During Period, Value, Acquisitions \| $	$ 11,544,855
For Success Holdings Company [Member]
Business Acquisition, Date of Transaction	Feb. 21, 2019
Issuance of shares under business combinations and investments \| shares	779,690
Stock Issued During Period, Value, Acquisitions \| $	$ 6,686,432
Integral Associates, LLC [Member]
Business Acquisition, Date of Transaction	Jun. 05, 2019
Issuance of shares under business combinations and investments \| shares	537,240
Stock Issued During Period, Value, Acquisitions \| $	$ 4,654,526

Share Capital - Additional of Information (Detail) - USD ($)										1 Months Ended	9 Months Ended
	Aug. 31, 2020	Aug. 26, 2020	Aug. 12, 2020	Aug. 07, 2020	Jun. 29, 2020	May 15, 2020	Feb. 10, 2020	Dec. 31, 2019	May 15, 2019	Jun. 30, 2018	Sep. 30, 2020
Distribution of deferred shares, Shares						101,695		1,367,643
Issuance of shares under contingent consideration											2,713,463
Distribution of deferred shares								$ 16,587,798			$ 1,835,331
Ohio Investors 2017 LLC [Member]
Issuance of shares under business combinations and investments				1,315,789
Issuance of shares under business combinations and investments, Value	$ 20,078,940
Redeemable Noncontrolling Interest, Equity, Fair Value				$ 11,200,000
Noncontrolling partners interest periodic increase decrease	$ 8,878,940			$ 20,078,940
KW Ventures LLC [Member]
Issuance of shares under business combinations and investments							48,450
Issuance of shares under business combinations and investments, Value							$ 400,413
Advanced Grow Labs LLC [Member]
Issuance of shares under contingent consideration											1,396,533
Restricted Stock Units (RSUs) [Member]
Cost Not yet Recognized, Amount											$ 25,815,117
Cost Not yet Recognized, Period for Recognition											1 year 11 months 4 days
GTII Stock and Incentive Plan [Member]
Percentage of maximum number of shares issued under the plan										10.00%
Multiple Voting Shares [Member]
Conversion of Stock, Shares Issued											(252,440)
Common Stock, Shares, Outstanding								373,350			120,910
Multiple Voting Shares [Member] \| Conversion Of Multiple Voting Shares [Member]
Conversion Of Stock, Shares Converted											252,440
Common Stock Conversion Basis											Each Multiple Voting Share is entitled to 100 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares.
Voting Rights											100
Subordinate Voting Shares [Member]
Conversion of Stock, Shares Issued											27,539,300
Common Stock, Shares, Outstanding								128,999,964			162,999,921
Issuance of shares under business combinations and investments											238,450
Distribution of deferred shares, Shares											1,220,548
Issuance of shares under contingent consideration											2,713,463
Subordinate Voting Shares [Member] \| Rise Canton [Member]
Issuance of shares under business combinations and investments, Value									$ 1,307,798
Subordinate Voting Shares [Member] \| MC Brands LLC [Member]
Issuance of shares under business combinations and investments					190,000
Issuance of shares under business combinations and investments, Value					$ 1,840,009
Subordinate Voting Shares [Member] \| Advanced Grow Labs LLC [Member]
Issuance of shares under business combinations and investments			472,500
Issuance of shares under business combinations and investments, Value			$ 538,000
Subordinate Voting Shares [Member] \| Success Holdings [Member]
Issuance of shares under business combinations and investments		646,353
Issuance of shares under business combinations and investments, Value		$ 8,064,668
Subordinate Voting Shares [Member] \| Conversion Of Multiple Voting Shares [Member]
Conversion of Stock, Shares Issued											25,244,000
Shares Available For Conversion											12,091,000
Subordinate Voting Shares [Member] \| Conversion Of Super Voting Shares [Member]
Conversion of Stock, Shares Issued											2,295,300
Super Voting Shares [Member]
Conversion of Stock, Shares Issued											(22,953)
Common Stock, Shares, Outstanding								402,289			379,336
Super Voting Shares [Member] \| Conversion Of Super Voting Shares [Member]
Conversion Of Stock, Shares Converted											22,953
Common Stock Conversion Basis											Each Super Voting Share is entitled to 1,000 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares
Voting Rights											1,000
Shares Available For Conversion											37,933,600

Other Income (Expense) - Schedule of Other Nonoperating Income (Expense) (Detail) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Fair value adjustments on equity investments	$ 8,134,213	$ (1,196,676)	$ 8,117,178	$ (932,983)	$ (5,459,462)
Fair value adjustments on variable note receivable		(5,428,542)	(815,937)	(7,424,727)
Fair value adjustments on warrants issued	(3,181,114)		(2,060,771)
Fair value adjustments on contingent consideration	442,991		425,426
Other	1,036,793	39,678	1,835,670	388,277
Total Other Income (Expense)	$ 6,432,883	$ (6,585,540)	$ 7,501,566	$ (7,969,433)

Commitments and Contingencies - Additional of Information (Detail)	9 Months Ended	12 Months Ended
	Sep. 30, 2020 USD ($)	Dec. 31, 2019
Construction Commitments [member]
Disclosure of Commitments and Contingencies [Line Items]
Contractual Obligation	$ 25,600,000
Reimbursement of Contractual Obligation	$ 22,500,000
Pending Litigation [member]
Disclosure of Commitments and Contingencies [Line Items]
Loss Contingency, Number of Plaintiffs	0	0
Threatened Litigation [member]
Disclosure of Commitments and Contingencies [Line Items]
Loss Contingency, Number of Plaintiffs	0	0

Fair Value Measurements - Fair Value Measurements, Recurring and Nonrecurring (Detail) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	$ 675,594
Warrant Liability	(18,513,000)	$ (15,879,843)
Financial Instruments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	78,091,073	46,667,334
Notes Receivable		815,937
Investments	22,210,999	14,068,821
Liability of Redemption of Noncontrolling Interest		(5,500,000)
Contingent Consideration Payable	(36,315,360)	(58,936,739)
Warrant Liability	(18,513,000)	(15,879,843)
FairValueNetAssetLiability	45,473,712	(18,764,490)
Fair Value, Inputs, Level 1 [member] \| Financial Instruments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	78,091,073	46,667,334
Investments	675,594
Liability of Redemption of Noncontrolling Interest
Contingent Consideration Payable
Warrant Liability
FairValueNetAssetLiability	78,766,667	46,667,334
Fair Value, Inputs, Level 2 [member] \| Financial Instruments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents
Investments
Liability of Redemption of Noncontrolling Interest
Contingent Consideration Payable
Warrant Liability
FairValueNetAssetLiability
Fair Value, Inputs, Level 3 [member] \| Financial Instruments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents
Notes Receivable		815,937
Investments	21,535,406	14,068,821
Liability of Redemption of Noncontrolling Interest		(5,500,000)
Contingent Consideration Payable	(36,315,360)	(58,936,739)
Warrant Liability	(18,513,000)	(15,879,843)
FairValueNetAssetLiability	$ (33,292,954)	$ (65,431,824)

Fair Value Measurements - Additional of Information (Detail)	Sep. 30, 2020 USD ($)
Disclosure Text Block Supplement [Abstract]
Investments Fair Value	$ 675,594

Variable Interest Entities - Schedule of Variable Interest Entities (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Variable Interest Entity [Line Items]
Current assets	$ 159,059,237		$ 159,059,237		$ 109,062,611
Current liabilities	105,898,809		105,898,809		111,367,255
Chesapeake Alternatives LLC [member]
Variable Interest Entity [Line Items]
Equity attributable to noncontrolling interests	298,252		298,252		350,206
Equity attributable to Green Thumb Industries Inc.	10,457,386		10,457,386		6,645,263
Revenues	5,684,349	$ 4,369,436	14,792,710	$ 12,458,427
Net income (loss) attributable to noncontrolling interests	26,134	1,807,394	206,929	2,244,546
Net income (loss) attributable to Green Thumb Industries Inc.	1,033,650	(971,880)	3,812,121
Net income (loss)	1,059,784	835,514	4,019,050	2,244,546
Chesapeake Alternatives LLC [member] \| Variable Interest Entity, Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Current assets	29,728,652		29,728,652		19,455,533
Non-current assets	3,041,401		3,041,401		22,384,663
Current liabilities	21,228,691		21,228,691		14,219,204
Non-current liabilities	785,724		785,724		1,169,989
Illinois Disp LLC [member]
Variable Interest Entity [Line Items]
Equity attributable to noncontrolling interests	2,309,983		2,309,983		2,089,071
Equity attributable to Green Thumb Industries Inc.	2,309,983		2,309,983		2,089,070
Revenues	5,224,583	1,620,065	13,170,514	4,174,045
Net income (loss) attributable to noncontrolling interests	897,494	185,930	2,170,912	506,972
Net income (loss) attributable to Green Thumb Industries Inc.	897,494	185,931	2,170,913	506,972
Net income (loss)	1,794,988	371,860	4,341,825	1,013,943
Illinois Disp LLC [member] \| Variable Interest Entity, Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Current assets	2,489,118		2,489,118		1,381,716
Non-current assets	3,752,645		3,752,645		3,083,659
Current liabilities	898,661		898,661		149,498
Non-current liabilities	473,136		473,136		137,736
Other Non material VIEs [member]
Variable Interest Entity [Line Items]
Equity attributable to noncontrolling interests	85,561		85,561		(22,488)
Equity attributable to Green Thumb Industries Inc.	2,619,001		2,619,001		2,270,598
Revenues	2,695,781	689,097	6,778,501	2,373,042
Net income (loss) attributable to noncontrolling interests	185,452	(1,624,850)	319,511	(2,307,097)
Net income (loss) attributable to Green Thumb Industries Inc.	294,969	1,059,653	661,341
Net income (loss)	480,421	$ (565,197)	980,852	$ (2,307,097)
Other Non material VIEs [member] \| Variable Interest Entity, Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Current assets	2,261,685		2,261,685		1,352,935
Non-current assets	2,353,991		2,353,991		2,534,297
Current liabilities	1,108,292		1,108,292		783,682
Non-current liabilities	$ 802,823		$ 802,823		$ 855,440

Segment Reporting - Schedule of Revenues (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Revenues	$ 157,103,841	$ 67,990,907	$ 379,346,367	$ 140,630,847
Depreciation and Amortization	11,534,876	7,913,813	38,479,960	17,528,891
Income Taxes	28,436,332	3,624,333	56,964,047	4,706,000
Intersegment Eliminations and Corporate [Member]
Segment Reporting Information [Line Items]
Income Taxes		(2,576,000)		(6,083,333)
Operating Segments [Member] \| Consumer Packaged Goods Segment [Member]
Segment Reporting Information [Line Items]
Revenues	74,702,069	35,093,858	177,355,614	71,651,968
Depreciation and Amortization	10,029,857	7,226,614	33,089,808	16,100,635
Income Taxes	12,928,449	1,072,333	23,553,449	1,761,333
Operating Segments [Member] \| Retail Segment [Member]
Segment Reporting Information [Line Items]
Revenues	111,948,115	43,532,286	275,451,137	85,501,646
Depreciation and Amortization	1,505,019	687,199	5,309,152	1,428,256
Income Taxes	15,507.883	5,128,000	33,410,598	9,028,000
Intersegment Eliminations [Member]
Segment Reporting Information [Line Items]
Revenues	$ (29,546,343)	$ (10,635,237)	$ (73,460,384)	$ (16,522,767)

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

+ Details

Segment Reporting - Additional Information (Detail) - USD ($)	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2018
Goodwill	$ 373,081,716	$ 375,084,991	$ 39,204,360
Intangible Assets Net	409,655,517	435,246,898
Consumer Packaged Goods Segment [Member]
Goodwill	252,016,532	255,211,232	23,918,000
Retail Segment [Member]
Goodwill	121,065,184	119,873,759	$ 15,286,360
Operating Segments [Member] \| Consumer Packaged Goods Segment [Member]
Goodwill	252,016,532	255,211,232
Intangible Assets Net	215,986,854	228,244,254
Operating Segments [Member] \| Retail Segment [Member]
Goodwill	121,065,184	119,873,759
Intangible Assets Net	$ 193,668,663	$ 207,002,644